<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN"  "JATS-archivearticle1-3-mathml3.dtd"><?covid-19-tdm ?><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">99833</article-id><article-id pub-id-type="doi">10.7554/eLife.99833</article-id><article-id pub-id-type="doi" specific-use="version">10.7554/eLife.99833.3</article-id><article-version article-version-type="publication-state">version of record</article-version><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Accurate predictions of SARS-CoV-2 infectivity from comprehensive analysis</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Park</surname><given-names>Jongkeun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Choi</surname><given-names>WonJong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Seong</surname><given-names>Do Young</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="equal-contrib1">†</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Jeong</surname><given-names>Seungpil</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Ju Young</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Hyo Jeong</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Chung</surname><given-names>Dae Sun</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yi</surname><given-names>Kijong</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Uijin</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Yoon</surname><given-names>Ga-Yeon</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con10"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Hyeran</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con11"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Taehoon</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con12"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Ko</surname><given-names>Sooyeon</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="con13"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Min</surname><given-names>Eun Jeong</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="con14"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Hyun-Soo</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-4067-4715</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con15"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Nam-Hyuk</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con16"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Hong</surname><given-names>Dongwan</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7816-1299</contrib-id><email>dwhong@catholic.ac.kr</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con17"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01fpnj063</institution-id><institution>Department of Medical Informatics, College of Medicine, The Catholic University of Korea</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05apxxy63</institution-id><institution>Graduate School of Medical Science and Engineering, Korea Advanced Institute and Technology</institution></institution-wrap><addr-line><named-content content-type="city">Daejeon</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01wjejq96</institution-id><institution>Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>Department of Microbiology and Immunology, Seoul National University College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>Department of Biomedical Sciences, Seoul National University College of Medicine</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>School of Chemical and Biological Engineering, Seoul National University</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01fpnj063</institution-id><institution>Department of Medical Life Sciences, College of Medicine, The Catholic University of Korea</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cb3km46</institution-id><institution>Seoul National University Bundang Hospital</institution></institution-wrap><addr-line><named-content content-type="city">Seongnam</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01fpnj063</institution-id><institution>Precision Medicine Research Center, College of Medicine, The Catholic University of Korea</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01fpnj063</institution-id><institution>Cancer Evolution Research Center, College of Medicine, The Catholic University of Korea</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/01fpnj063</institution-id><institution>CMC Institute for Basic Medical Science, the Catholic Medical Center of The Catholic University of Korea</institution></institution-wrap><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff><aff id="aff12"><label>12</label><institution>INNOONE</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ng</surname><given-names>Alvin WT</given-names></name><role>Reviewing Editor</role><aff><institution>Lee Kong Chian School of Medicine</institution><country>Singapore</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Choi</surname><given-names>Murim</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/04h9pn542</institution-id><institution>Seoul National University</institution></institution-wrap><country>Republic of Korea</country></aff></contrib></contrib-group><author-notes><fn fn-type="con" id="equal-contrib1"><label>†</label><p>These authors contributed equally to this work</p></fn></author-notes><pub-date publication-format="electronic" date-type="publication"><day>24</day><month>12</month><year>2024</year></pub-date><volume>13</volume><elocation-id>RP99833</elocation-id><history><date date-type="sent-for-review" iso-8601-date="2024-06-14"><day>14</day><month>06</month><year>2024</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint.</event-desc><date date-type="preprint" iso-8601-date="2024-06-14"><day>14</day><month>06</month><year>2024</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2024.06.14.598983"/></event><event><event-desc>This manuscript was published as a reviewed preprint.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-10-21"><day>21</day><month>10</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.99833.1"/></event><event><event-desc>The reviewed preprint was revised.</event-desc><date date-type="reviewed-preprint" iso-8601-date="2024-12-06"><day>06</day><month>12</month><year>2024</year></date><self-uri content-type="reviewed-preprint" xlink:href="https://doi.org/10.7554/eLife.99833.2"/></event></pub-history><permissions><copyright-statement>© 2024, Park, Choi, Seong et al</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>Park, Choi, Seong et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-99833-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-99833-figures-v2.pdf"/><abstract><p>An unprecedented amount of SARS-CoV-2 data has been accumulated compared with previous infectious diseases, enabling insights into its evolutionary process and more thorough analyses. This study investigates SARS-CoV-2 features as it evolved to evaluate its infectivity. We examined viral sequences and identified the polarity of amino acids in the receptor binding motif (RBM) region. We detected an increased frequency of amino acid substitutions to lysine (K) and arginine (R) in variants of concern (VOCs). As the virus evolved to Omicron, commonly occurring mutations became fixed components of the new viral sequence. Furthermore, at specific positions of VOCs, only one type of amino acid substitution and a notable absence of mutations at D467 were detected. We found that the binding affinity of SARS-CoV-2 lineages to the ACE2 receptor was impacted by amino acid substitutions. Based on our discoveries, we developed APESS, an evaluation model evaluating infectivity from biochemical and mutational properties. In silico evaluation using real-world sequences and in vitro viral entry assays validated the accuracy of APESS and our discoveries. Using Machine Learning, we predicted mutations that had the potential to become more prominent. We created AIVE, a web-based system, accessible at <ext-link ext-link-type="uri" xlink:href="https://ai-ve.org">https://ai-ve.org</ext-link> to provide infectivity measurements of mutations entered by users. Ultimately, we established a clear link between specific viral properties and increased infectivity, enhancing our understanding of SARS-CoV-2 and enabling more accurate predictions of the virus.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>SARS-CoV-2</kwd><kwd>infectivity</kwd><kwd>protein prediction</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2021M3H9A2097227</award-id><principal-award-recipient><name><surname>Hong</surname><given-names>Dongwan</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF-2022R1A2C3008162</award-id><principal-award-recipient><name><surname>Hong</surname><given-names>Dongwan</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>RS-2023-00220840</award-id><principal-award-recipient><name><surname>Hong</surname><given-names>Dongwan</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003710</institution-id><institution>Korea Health Industry Development Institute</institution></institution-wrap></funding-source><award-id>RS-2023-00265923</award-id><principal-award-recipient><name><surname>Hong</surname><given-names>Dongwan</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003725</institution-id><institution>National Research Foundation of Korea</institution></institution-wrap></funding-source><award-id>NRF: 2021M3A9I2080490</award-id><principal-award-recipient><name><surname>Cho</surname><given-names>Nam-Hyuk</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100003710</institution-id><institution>Korea Health Industry Development Institute</institution></institution-wrap></funding-source><award-id>RS-2024-00406488</award-id><principal-award-recipient><name><surname>Park</surname><given-names>Jongkeun</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Big data analysis, protein structure prediction, and artificial intelligence are integrated to predict novel and highly transmissible SARS-CoV-2 variants.</meta-value></custom-meta><custom-meta specific-use="meta-only"><meta-name>publishing-route</meta-name><meta-value>prc</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>The importance of big data science has led to the accumulation of huge amounts of data, recently, a generative AI model with a large language model (LLM) using various types of big data has further been emerging across various fields, including healthcare, omics research, and industry (<xref ref-type="bibr" rid="bib36">Thirunavukarasu et al., 2023</xref>; <xref ref-type="bibr" rid="bib41">Yang et al., 2022</xref>). In response to the continuous emergence of new SARS-CoV-2 variants, our study introduces an innovative model and platform that integrates big data analysis, protein structure prediction using AlphaFold, and AI learning to predict highly transmissible novel SARS-CoV-2 variants. The validation of predictions made using AI is crucial, so we present the proofs through in-silico and in-vitro experiments for highly infectious variants.</p><p>The COVID-19 pandemic-related deaths have decreased, but the infectivity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) persists. This may be because of neutralizing antibodies from previous infections or numerous mutations in the virus, from the Alpha variant to current Omicron sublineages (<xref ref-type="bibr" rid="bib37">Tsai et al., 2021</xref>; <xref ref-type="bibr" rid="bib10">Cao et al., 2022</xref>).</p><p>Genomic databases, such as Nextstrain and the Global Initiative on Sharing All Influenza Data (GISAID), Our World in Data (OWID), containing epidemiological data, have been instrumental in collecting valuable data during the COVID-19 pandemic (<xref ref-type="bibr" rid="bib34">Shu and McCauley, 2017</xref>; <xref ref-type="bibr" rid="bib25">Mathieu et al., 2021</xref>; <xref ref-type="bibr" rid="bib12">Hadfield et al., 2018</xref>). Reports on the current global efforts of genomic surveillance strategies and sequencing show varied levels of data accumulation (<xref ref-type="bibr" rid="bib11">Chen et al., 2022</xref>). Nonetheless, the increasing amount of available SARS-CoV-2 data has made various analytical approaches possible.</p><p>SARS-CoV-2 mutations can alter gene function. For example, the SARS-CoV-2 furin gene plays an important role in the cleavage of the spike protein, and mutations in the gene significantly affect SARS-CoV-2 fusion with the host cell membrane (<xref ref-type="bibr" rid="bib28">Peacock et al., 2021</xref>; <xref ref-type="bibr" rid="bib19">Johnson et al., 2021</xref>). Mutations in the genes have a direct impact on its protein structure, influencing the pathway used by the virus to infect host cell (<xref ref-type="bibr" rid="bib7">Bouhaddou et al., 2023</xref>). Mutations in the spike protein lead to differences in the protein structure and binding affinity to ACE2, the receptor through which the virus penetrates the host cell (<xref ref-type="bibr" rid="bib1">Ali et al., 2021</xref>; <xref ref-type="bibr" rid="bib32">Seyran et al., 2021</xref>).</p><p>Deep learning methods predict mutations and protein structures, and their application in research has led to enhanced genomic analysis with large datasets (<xref ref-type="bibr" rid="bib31">Senior et al., 2020</xref>; <xref ref-type="bibr" rid="bib35">Theodosiou and Read, 2023</xref>). This approach has proved valuable in predicting disease-related mutations and identifying genes of interest (<xref ref-type="bibr" rid="bib40">Yang et al., 2021</xref>). Recently, deep learning has been utilized to analyze mutations in SARS-CoV-2 (<xref ref-type="bibr" rid="bib5">Berman et al., 2023</xref>; <xref ref-type="bibr" rid="bib43">Zhou et al., 2023</xref>). Prediction models, such as AlphaFold2, have been used to assess protein 3D structures (<xref ref-type="bibr" rid="bib20">Jumper et al., 2021</xref>). This has led to the detection of structural changes caused by mutations in Delta (B.1.617.2) and Omicron (B.1.1.529) (<xref ref-type="bibr" rid="bib6">Bhowmick et al., 2022</xref>). Alphafold2 has also been used to analyze protein genotypes and phenotypes in the RBD region (<xref ref-type="bibr" rid="bib22">Kilim et al., 2023</xref>). Furthermore, hydrophobic properties in the amino acid sequence affect protein folding (<xref ref-type="bibr" rid="bib24">Lins and Brasseur, 1995</xref>). Coronavirus hydrophobicity has significant effects on amino acid properties and protein folding (<xref ref-type="bibr" rid="bib33">Shekhawat and Roy Chowdhury Chakravarty, 2022</xref>).</p><p>For these prior approaches to virus analysis and prediction, expertise in the relevant fields is required for a full understanding. Also, structure-based predictions of mutations cannot fully account for all aspects of SARS-CoV-2 infection. In this study, we analyzed SARS-CoV-2 mutations using artificial intelligence (AI) methods and leveraged large datasets to elucidate properties of the virus and make various predictions. We discovered amino acid polarity changes and substitutions and then evaluated the infectivity from significant mutations in the RBM region. We specifically examined the effect of protein structures from hydrophobicity to hydrophilic and alkaline properties.</p><p>Our evaluation involved a comprehensive analysis of epidemiological, and genomic data, capitalizing on the availability of large SARS-CoV-2 datasets. We extracted properties from the VOCs and each sublineage at the nucleotide and amino acid levels. We developed an evaluation model called amino acid property eigen selection score (APESS) to analyze SARS-CoV-2 sequences. Various methods were utilized to validate our findings, and we used machine learning to make further predictions.</p><p>Finally, we present our findings and evaluation models through the Artificial Intelligence Analytics Toolkit for predicting virus mutations in protEin (AIVE), a web-based platform that integrates SARS-CoV-2 data, visualizes APESS score distribution, offers 3D protein predictions, and increases accessibility for researchers. Overall, our research provides a model for pandemic preparedness and the study of infectious diseases.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Discovery of significant properties in the amino acid sequence</title><p>We examined the amino acid sequences of SARS-CoV-2 to make discoveries about biochemical properties. We identified consecutive hydrophilic amino acids within the SARS-CoV-2 spike protein in the following lineages: Wuhan-Hu-1, Alpha, Beta, and Omicron (BA.1, BA.2, BA.2.75, BA.4/BA.5, XBB, BQ.1). A series of hydrophilic amino acid regions were observed in the RBM region (amino acid sequence 437–508). In specific SARS-CoV-2 lineages, amino acid substitutions were observed in these regions (<xref ref-type="fig" rid="fig1">Figure 1A</xref>, <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>). For example, the Delta and Omicron lineages contained a substitution of T478K of alkaline amino acids.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Analysis of protein properties discovered in the SARS-CoV-2 amino acid sequence.</title><p>(<bold>A</bold>) The SARS-CoV-2 amino acid sequence between positions 437 and 508 in the receptor binding motif (RBM) is displayed with the corresponding amino acids in the original positions. Amino acid substitutions are shown for Alpha, Beta, Delta, Omicron BA.1, Omicron BA.2, Omicron BA.4/BA.5, Omicron BQ.1, and Omicron XBB. Hydrophilic (polar) amino acids are displayed in red, hydrophobic (non-polar) in blue, acidic in green, and alkaline (positively charged) in yellow. (<bold>B</bold>) The number of polarity changes [N: hydrophobic (nonpolar), P: hydrophilic (polar), A: acidic, and B: alkaline (basic)] in the receptor binding domain (RBD) region is displayed. Wuhan-Hu-1, Alpha, Beta, Delta, Omicron (BA.1), Omicron (BA.2), Omicron (BA.2.75), Omicron (BA.4/BA.5), Omicron (XBB), and Omicron (BQ.1) are presented on the graph with each lineage color-coded. The polarity change count for NN*, NP*, PN*, and PP* are shown in more detail. PN* (Wuhan-Hu-1: 39, Alpha: 39, Beta: 40, Delta: 37, Omicron BA.1: 36, Omicron BA.2: 35, Omicron BA.2.75: 35, Omicron BA.4/BA.5: 34, Omicron XBB: 36, Omicron BQ.1: 34) PP* (Wuhan-Hu-1: 31, Alpha: 31, Beta: 31, Delta: 30, Omicron BA.1: 27, Omicron BA.2: 26, Omicron BA.2.75: 26, Omicron BA.4/BA.5: 27, Omicron XBB: 29, Omicron BQ.1: 27). Overall, polarity decreased from PN* to PP* across all SARS-CoV-2 lineages. (<bold>C</bold>) The amino acid substitutions in the RBM region from the reference to VOCs are displayed. The seventeen amino acids in the reference list are tyrosine (<bold>Y</bold>), threonine (<bold>T</bold>), serine (<bold>S</bold>), glutamine (<bold>Q</bold>), asparagine (<bold>N</bold>), cysteine (<bold>C</bold>), valine (<bold>V</bold>), proline (<bold>P</bold>), leucine (<bold>L</bold>), isoleucine (<bold>I</bold>), glycine (<bold>G</bold>), phenylalanine (<bold>F</bold>), alanine (<bold>A</bold>), arginine (<bold>R</bold>), lysine (<bold>K</bold>), glutamic acid (<bold>E</bold>), and aspartic acid (<bold>D</bold>). For variants of concerns (VOCs), the amino acid substitutions are indicated by gray lines. There was a more than twofold increase in lysine (<bold>K</bold>) and arginine (<bold>R</bold>) in VOCs compared with the reference.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Research Overview.</title><p>AIVE can perform comprehensive analyses of SARS-CoV-2 mutations entered by the User. From the World Health Organization (WHO), we obtained data from variants of concern (VOCs) and variants under monitoring (VUMs) and lineage mutation data from outbreak.info. Epidemiological data was obtained from Our World in Data (OWID) to provide the number of infections, deaths, vaccinations, and reproduction rate. From Global Initiative on Sharing All Influenza Data (GISAID), virus sequence data and epidemiological data were collected. Through comprehensive analysis of databases, mutation prediction, evaluation, and epidemiological analysis based on mutation properties was carried out, and a web-based platform (AIVE) was created.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig1-figsupp1-v2.tif"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 2.</label><caption><title>Amino acid substitutions in spike proteins from variants of concerns (VOCs).</title><p>To show the changes of mutations according to evolution from Alpha to Omicron, we provide the Sankey diagram of each lineage. In VOCs (Alpha, Beta, Omicron BA.1, BA.2, BA.2.75, BA.4, BA.5, XBB, BQ.1), differences in amino acid substitutions were observed for each lineage compared to the reference. For Omicron sublineages, tyrosine (Y) is substituted for histidine (H). Also, there is an increase in lysine (K) and arginine (R) compared to the reference. The title of each lineage is as follows: (<bold>A</bold>) Alpha, (<bold>B</bold>) Beta, (<bold>C</bold>) Omicron BA.1, (<bold>D</bold>) Omicron BA.2, (<bold>E</bold>) Omicron BA.2.75, (<bold>F</bold>) Omicron BA.4, (<bold>G</bold>) Omicron BA.5, (<bold>H</bold>) Omicron XBB, and (<bold>I</bold>) Omicron BQ.1.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig1-figsupp2-v2.tif"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 3.</label><caption><title>Polarity changes in the spike protein region of coronavirus and characteristics of RNA and amino acid levels of SARS-CoV-2.</title><p>(<bold>A</bold>) The polarity of coronavirus: SARS-CoV-1, MERS-CoV, and SARS-CoV-2 are displayed. hydrophilic (<bold>N</bold>), hydrophobic (<bold>P</bold>), acidic (<bold>A</bold>), and basic (<bold>B</bold>). (<bold>B</bold>) The number of amino acids in the receptor binding motif (RBM) region for SARS-CoV-2 lineages (Wuhan-Hu-1, Alpha, Beta, Delta, BA.1, BA.2, BA.2.75, BA.4, XBB, and BQ.1) are displayed. As SARS-CoV-2 lineages progress from Wuhan-Hu-1 to Omicron, hydrophilic (polar) and hydrophobic (non-polar) amino acids are maintained at higher numbers. Meanwhile, there has been a slight increase in basic amino acids. There has not been a significant change in acidic amino acids. (<bold>C</bold>) Transition and transversion rates for Adenine (<bold>A</bold>), Guanine (<bold>G</bold>), Cytosine (<bold>C</bold>), and Uracil (<bold>U</bold>) were counted and displayed (Red: transversions and Blue: transitions) for the spike protein of the 7,335,614 samples. (<bold>D</bold>) We summarized the occurrences of SARS-CoV-2 mutations for the three codon positions comprising amino acids and investigated the mutation rate in the lineages (Alpha, Beta, Delta, Omicron (BA.2.75), Omicron (BA.4/BA.5), Omicron (XBB), Omicron BQ.1). The mutation rate for each codon position showed different values for each lineage. The mutation occurrence rate for the second codon position was over 50% on average for all lineages. In the case of the Delta variant, the mutation rate for the second codon position was the highest among all variants at 76.94%. (<bold>E</bold>) The amino acid substitutions are displayed, and the size of the circle signifies the rate of change for the mutations against the reference. Lysine (<bold>K</bold>), arginine (<bold>R</bold>), and alanine (<bold>A</bold>) have the highest rate of change at over 200%.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig1-figsupp3-v2.tif"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 4.</label><caption><title>Polarity change analysis due to mutation in the amino acid sequence of MERS-CoV.</title><p>The amino acid sequence for MERS-CoV, a known coronavirus like SARS-CoV-2, and the mutations are displayed. The red indicates hydrophilic (polar), the blue indicates hydrophobic (non-polar), the green indicates acidic, and the yellow indicates alkaline (basic) amino acids. In MERS-CoV, a limited number of mutations were found. Notably, the S390F, L411F, T424I, F473S, D510S, P515L, I529T, L588L, and A597A mutations. In characteristics of MERS-CoV mutations, consecutive hydrophilic patterns are found in MERS-CoV, which the mutations do not disrupt.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig1-figsupp4-v2.tif"/></fig></fig-group><p>Each position showed differences in the number of polarity changes; specifically, changes from hydrophilic (polar, P) to hydrophobic (non-polar, N) or positively charged amino acids. For most positions, we did not detect significant differences in polarity between the lineages investigated (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a–c</xref>).</p><p>As the virus progressed from the Wuhan-Hu-1 (40 in NN* and 31 in PP*) to Omicron (average 45.5 in NN* and average 27 in PP*), the number of polarity changes increased in NN* while decreasing in PP*. For these positions, polarity changes occurred in the lineages as they evolved to the Omicron variant (<xref ref-type="fig" rid="fig1">Figure 1B</xref>). More polarity changes occurred in Delta, XBB, Omicron BQ.1, and Omicron BA.4/BA.5 than in the other VOCs.</p><p>We investigated the amino acid substitutions in the VOCs and compared them with the Wuhan-Hu-1 sequence as the reference. We discovered a twofold increase in amino acid substitutions to lysine (K) and arginine (R) in later SARS-CoV-2 lineages. Meanwhile, glutamine (Q), phenylalanine (F), and glutamic acid (E) levels decreased by half in the VOCs. For phenylalanine (F), hydrophobic residue mutations occurred in areas irrelevant to the regions of consecutive hydrophilic amino acids (<xref ref-type="fig" rid="fig1">Figure 1C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref> and <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2</xref>).</p><p>Various coronaviruses, including MERS-CoV, SARS-CoV-1, and SARS-CoV-2, did not show significant differences in polarity across positions (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3A</xref>).</p><p>We investigated the polarity (hydrophilic, hydrophobic, alkaline, and acidic) of amino acids in Wuhan-Hu-1, Alpha, Beta, Omicron (BA.1, BA.2, BA.2.75, BA.4/BA/5, XBB, BQ.1), and the number of amino acids in the RBM sequence. Most amino acids were either hydrophilic or hydrophobic across lineages, with a slight increase in alkaline amino acid levels in the Omicron variants than in the others (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3B</xref>).</p><p>We investigated the nucleotide sequences of the SARS-CoV-2 spike protein gene. We analyzed the transitions and transversions of 7,335,614 samples from the GISAID viral sequence. The rate of change from G to U was higher than that of U to G, and the rate from C to U was higher than that of U to C. Both C to G and G to C rates were extremely low (<xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1e</xref>, <xref ref-type="bibr" rid="bib27">Panchin and Panchin, 2020</xref>; <xref ref-type="bibr" rid="bib42">Yi et al., 2021</xref>).</p></sec><sec id="s2-2"><title>Identification of properties in amino acid substitutions</title><p>We studied each mutation in the RBM region of lineages and sublineages using verified mutation data: Alpha, Beta, Delta, Omicron (BA.2.75), Omicron (BA.4/BA.5), Omicron (XBB), and Omicron (BQ.1).</p><p>From the viral sequences submitted to GISAID, we extracted data (n=7,335,614) of the sublineages defined on the outbreak.info platform. The most noteworthy mutations were N440, L452, S477, T478, E484, F486, N501, and Y505 (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). Only seven individuals possessed mutations at D467 out of the 7,335,614 investigated (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1A</xref>).</p><fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Evaluation and validation of amino acid substitutions in the SARS-CoV-2 receptor binding motif (RBM) region.</title><p>(<bold>A</bold>) Mutations, their occurrence rates as percentages, and the original amino acid at the position are shown. Alpha, Beta, Delta, Omicron (BA.2.75), Omicron (BA.4/BA.5), Omicron (XBB), and Omicron (BQ.1) lineages are displayed with corresponding colors. N440, L452, S477, T478, E484, F486, N501, and Y505 are indicated by yellow triangles while D467 is indicated by a red triangle. (<bold>B</bold>) For positions N440, L452, S477, T478, E484, F486, N501, and Y505, lineages and amino acid substitutions are displayed. Arrows indicate the mutation rate where width corresponds with the percentage and the colors indicate lineages Alpha, Beta, Delta, Omicron (BA.2.75), Omicron (BA.4/BA.5), Omicron (XBB), and Omicron (BQ.1). The colors in the pie chart indicate amino acids. The mutation rate of Alpha is lower than 20%. At the 501st position in the RBM region, amino acid substitutions from asparagine (<bold>N</bold>) to tyrosine (<bold>Y</bold>) (n=282) occurred along with other substitutions. For the Beta variant, the 484<sup>th</sup> position showed a mutation rate over 60% with E484K. The Delta variant showed a mutation rate of 60% at the 452nd position. L452R and T478K amino acid substitutions along with various mutations were observed. In Omicron, the mutation rate for S477, T478, E484, N501, and Y505 was over 40%. The amino acid substitutions were S477K, T478K, E484A, N501Y, and Y505H. We calculated the mutation rates for the following positions: T478K (99.95%), Q498R (94.14%), N501Y (99.52%), and Y505H (97.66%). (<bold>C</bold>) The effect of the D467 amino acid substitution on viral infection was evaluated in vitro via luciferase and viral entry assays. Mutagenesis at D467 to hydrophobic amino acids proline (<bold>P</bold>) and isoleucine (<bold>I</bold>) was performed. There was a significant decrease in the RLU and viral entry percentages for both D467P and D467I (&lt;0.0001).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig2-v2.tif"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 1.</label><caption><title>Presence of D467 mutation from Global Initiative on Sharing All Influenza Data (GISAID) and evaluation of protein structure due to D467.</title><p>(<bold>A</bold>) Of the investigated sequences, there are very few instances of D467 amino acid substitutions. In the Delta variant, D467V was observed. In the Omicron BA.1.15 variant, D467V was observed. In the Omicron BA.2 variant, D467E, D467H, D467E, and D467K were observed. In the Omicron BA.2.9 variant, D467G was observed. (<bold>B</bold>) The pLDDT scores are displayed on the y-axis for the graphs. Protein structure prediction of mutagenesis sequences at D467 showed that there was a general decrease in predicted local distance difference test (pLDDT) score compared to VOCs. For SARS-CoV-2 variants, mutagenesis at D467 to lysine (<bold>K</bold>), arginine (<bold>R</bold>), glycine (<bold>G</bold>), tyrosine (<bold>Y</bold>), asparagine (<bold>N</bold>), serine (<bold>S</bold>) was carried out for Wuhan-Hu-1, Alpha, Beta, Delta, and Omicron (BA.1, BA.2, BA.2.75, BA.4/BA.5, XBB, BQ.1). We compared the pLDDT scores of the D467 mutagenesis variants against VOCs. For Wuhan-Hu-1 (47.96902778), Alpha (53.94541667), Delta (67.10597222), BA.1 (60.06305556), BA.2 (56.23902778), there was a general decrease in pLDDT score compared to variants of concerns (VOCs). For Beta (65.915), BA.5 (70.96763889), BQ.1 (51.05027778), they showed similar pLDDT scores compared to the VOCs. The BA.2.75 (55.45305556) variant showed an increase in pLDDT score. However, for the pLDDT scores of all SARS-CoV-2 variants, the fluctuation of the confidence score was extreme and the predicted aligned error (PAE) score was low as well.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig2-figsupp1-v2.tif"/></fig><fig id="fig2s2" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 2.</label><caption><title>Identification of protein expression using western blotting.</title><p>We measured the expression of exogenous spike proteins through western blotting for SARS-CoV-2 spike protein mutations. To compare to the wild-type (S-D614G), mutagenesis was done for N437R, N460K, D467P, D467I, and Q493R. Normalization was done with Beta-actin. The Beta actin bands are observed uniformly across the lanes for the vector, wild-type (D614G), and mutagenesis sequences. The molecular weight of bands are displayed in kDa.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig2-figsupp2-v2.tif"/></fig><fig id="fig2s3" position="float" specific-use="child-fig"><label>Figure 2—figure supplement 3.</label><caption><title>D467 protein 3D structure prediction.</title><p>Measuring the viral infectivity in vitro of the SARS-CoV-2 RBM sequence showed the structural importance of D467 (<xref ref-type="fig" rid="fig2">Figure 2C</xref>). In silico results of measuring the docking score between SARS-CoV-2 receptor binding motif (RBM) and the host ACE2 receptor showed contradicting results. Visualization of the SARS-CoV-2 folding structure displayed the wild-type D467D with an alpha-helix structure, indicated with a red triangle. Mutagenesis to D467P and D467I to the wild-type backbone resulted in the alpha helix structure turning into a linear structure. It becomes more likely for the protein 3D structure to become flexible.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig2-figsupp3-v2.tif"/></fig></fig-group><p>Importantly, the experimental results corroborated the amino acid substitutions observed in the viral sequences. Almost no mutations were found at the D467 position of the RBM sequence. In vitro experiments using a luciferase assay and viral entry experiments demonstrated that infectivity associated with D467 mutagenesis (D467P and D467I) was lower than the wild-type (spike protein D614G) (<xref ref-type="fig" rid="fig2">Figure 2C</xref>, <xref ref-type="fig" rid="fig2s2">Figure 2—figure supplement 2</xref>).</p><p>We investigated the mutation rates and amino acid substitutions in VOCs and variants under monitoring (VUMs). In the earlier Alpha, Beta, and Delta lineages, various amino acid changes occurred at multiple locations. In later lineages, we observed a reduction in the diversity of amino acid changes due to substitutions (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). L452R and T478K were the most numerous non-synonymous mutations while more synonymous mutations developed.</p></sec><sec id="s2-3"><title>Differences in molecular cell levels that affect infectivity and severity in the evolution of SARS-CoV-2</title><p>We investigated the molecular cell level differences that affect the severity and infectivity of SARS-CoV-2 in its evolutionary process. From 1/23/2020 to 12/31/2022, we examined the number of infections and deaths using data from OWID and compared the periods where lineages occurred. Based on epidemiological data, we established three main periods: the major outbreak period of Delta, Omicron BA.5, and Omicron BQ. During the Delta period, there was an increase in the ratio of deaths to infections, for the Omicron BA.5 period, both infections and deaths increased, and finally in the Omicron BQ period, both decreased (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). We attributed these trends to mutations in the major lineages and further investigation of sublineages through viral sequence information revealed stabilization per lineage (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1f and g</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Association between SARS-CoV-2 mutations and epidemiological data.</title><p>(<bold>A</bold>) For each SARS-CoV-2 lineage, the position and distribution of amino acid substitutions were analyzed alongside epidemiological data. The first period, from November 2020 to December 2021, was characterized by low infections and high deaths. Delta was the most prominent during this period, coinciding with worldwide vaccinations. Amino acid substitutions L452R and T478K were observed at the highest frequency while T478K and L452R were independently observed at the highest frequencies. The second period, from January 2022 to April 2022, saw an increase in the new cases and deaths. BA.5 was prominent during this period with various amino acid substitutions observed. The third period, from May 2022 to November 2022, showed a significant decrease in infections and deaths. Omicron, specifically BQ.1 was prominent during this period and worldwide vaccination rates decreased. (<bold>B</bold>) From the viral sequences of the patients, the association between the primary mutations of Delta, BA.5, and BQ.1, and epidemiological data (symptoms and severity) was analyzed. Odds ratios are displayed for L440K, K444T, L452R, N460K, S477N, T478K, E484A, F486V, Q498R, N501Y, and Y505H. L452R was an indicator of symptomaticity in Delta and BA.5. K477T was associated with symptomaticity in BQ.1. All mutations were associated with mildness. The 95% confidence intervals are shown for Delta, BA.5, and BQ.1. (<bold>C</bold>) We analyzed the expression of Delta compared to BA.4/BA.5 using the GSE235262 dataset. In Delta, the mTOR pathway was observed to regulate ribosome biogenesis, autophagy, and lipid biosynthesis while also playing a role in viral infection pathways. The expression values were calculated as Delta [log2(TPM +1)] / Omicron BA.4+BA.5 [log2(TPM +1)], with ENST Ensembl Transcript IDs, and * indicating a significance level of p&lt;0.05. (<bold>D</bold>) The folding structures and pDockQ scores (0.506, 0.569, 0.577, 0.560, 0.564, and 0.575 for Wuhan-Hu-1, Beta, Delta, BA.4/BA.5, BQ.1, and XBB, respectively) were shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-v2.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Prediction of spike protein 3D structures from Alpha Omicron BA.1 Omicron BA.2.</title><p>The folding structures and pDockQ scores of Alpha, Omicron (BA.1), and Omicron (BA.2) are displayed. The pDockQ scores are 0.522, 0.558, and 0.558, respectively.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp1-v2.tif"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 2.</label><caption><title>Binding affinity between SARS-CoV-2 and ACE2 receptor using HADDOCK.</title><p>(<bold>A</bold>) The root mean square deviation (RMSD) and HADDOCK scores are displayed for SARS-CoV-2 lineages Wuhan-Hu-1, Alpha, Beta, Delta, Omicron (BA.1), Omicron (BA.2), Omicron (BA.2.75), Omicron (BA.4/BA.5), Omicron (XBB), and Omicron (BQ.1). The SARS-CoV-2 lineages are shown on the graph with corresponding colors. The SARS-CoV-2 lineages with both higher RMSD and HADDOCK scores are indicated with an encompassing red circle. (<bold>B</bold>) For SARS-CoV-2 lineages Wuhan-Hu-1, Alpha, Beta, Delta, Omicron (BA.1), Omicron (BA.2), Omicron (BA.2.75), Omicron (BA.4/BA.5), Omicron (XBB), and Omicron (BQ.1), the van der waals energy, electrostatic energy, and desolvation energy are displayed in their respective graphs.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp2-v2.tif"/></fig><fig id="fig3s3" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 3.</label><caption><title>pDockQ scores of Wuhan-Hu-1 mutations.</title><p>pDockQ scores of lineages with the Wuhan-Hu-1 as the backbone, with each mutation N437R, N 460 K, D467I, D467P, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp3-v2.tif"/></fig><fig id="fig3s4" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 4.</label><caption><title>pDockQ scores of Alpha mutations.</title><p>pDockQ scores of lineages with the alpha lineages as the backbone, with each mutation N437R, N 460 K, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp4-v2.tif"/></fig><fig id="fig3s5" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 5.</label><caption><title>pDockQ scores of Beta mutations.</title><p>pDockQ scores of lineages with the beta lineages as the backbone, with each mutation N437R, N 460 K, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp5-v2.tif"/></fig><fig id="fig3s6" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 6.</label><caption><title>pDockQ scores of Delta mutations.</title><p>pDockQ scores of lineages with the delta lineages as the backbone, with each mutation N437R, N 460 K, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp6-v2.tif"/></fig><fig id="fig3s7" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 7.</label><caption><title>pDockQ scores of BA.1 mutations.</title><p>pDockQ scores of lineages with the omicron BA.1 as the backbone, with each mutation N437R, N 460 K, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp7-v2.tif"/></fig><fig id="fig3s8" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 8.</label><caption><title>pDockQ scores of BA.2 mutations.</title><p>pDockQ scores of lineages with the omicron BA.2 lineages as the backbone, with each mutation N437R, N460K, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp8-v2.tif"/></fig><fig id="fig3s9" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 9.</label><caption><title>pDockQ scores of BA.2.75 mutations.</title><p>pDockQ scores of lineages with the omicron BA.2.75 lineages as the backbone, with each mutation N437R, N460K, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp9-v2.tif"/></fig><fig id="fig3s10" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 10.</label><caption><title>pDockQ scores of BA.4 mutations.</title><p>pDockQ scores of lineages with the omicron BA.2.75 lineages as the backbone, with each mutation N437R, N460K, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp10-v2.tif"/></fig><fig id="fig3s11" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 11.</label><caption><title>pDockQ scores of BQ.1 mutations.</title><p>pDockQ scores of lineages with the omicron BQ1 lineages as the backbone, with each mutation N437R, N460K, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp11-v2.tif"/></fig><fig id="fig3s12" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 12.</label><caption><title>pDockQ scores of XBB mutations.</title><p>pDockQ scores of lineages with the omicron BA.2.75 lineages as the backbone, with each mutation N437R, N460K, D467R, and Q493R added.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig3-figsupp12-v2.tif"/></fig></fig-group><p>We investigated the epidemiological relationship between symptoms and disease severity in patients by examining mutations in the RBM region for major SARS-CoV-2 lineages and their sublineages. We found that these mutations became fixed over time (<xref ref-type="fig" rid="fig3">Figure 3B</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1h and</xref> i). In the Delta variant, a significant increase in symptomatic infections occurred for mutations L452R (odds ratio 4.346, 95% CI 2.378–8.191) and T478K (odds ratio 3.116, 95% CI 1.595–6.292). For most patients with Omicron BA.5 and BQ.1, mutations were asymptomatic. However, among patients with Omicron BQ.1 mutations, only those with K447T were symptomatic. The Delta, Omicron BA.5, and Omicron BA.1 variants more frequently produced milder outcomes with more mutations. Consequently, we showed that as SARS-CoV-2 evolves to Omicron, the number of asymptomatic patients with mild outcomes increased, with infection symptoms becoming less severe.</p><p>Since we cannot determine the severity and presence of symptoms in SARS-CoV-2 from mutations alone, we analyzed gene expression within host cells of infected patients. We utilized GSE235262 from the NCBI GEO database to analyze the gene expression of controls (uninfected), Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.529, BA.2, BA.4, and BA.5) variants during waves of COVID-19. In particular, we focused on the expression differences between Alpha (B.1.1.7) and Omicron (BA.4/BA.5), and between Delta (B.1.617.2) and Omicron (BA.4/BA.5), conducting enrichment analyses on genes that showed significant differences (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1j</xref>). Compared to Omicron (BA.4/BA.5), most genes in Delta (B.1.617.2) were up regulated in molecular and virus infection pathways (p&lt;0.05). Notably, in the mTOR pathway, there was a correlation with receptor genes leading to the PI3K-AKT pathway, lysosome, ribosome biogenesis, autophagy, and lipid biosynthesis, In the virus infection pathway, endocytosis and metabolic pathways were related (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Compared to Omicron (BA.4/BA.5), Delta is more associated with various pathways within the host cell, leading to inflammation, replication, and severity.</p><p>We believe that Omicron’s characteristics are not solely due to its molecular cell level features within the host cell but also stem from its evolution, affecting its binding affinity to the host’s ACE2. Therefore, we utilized pDockQ and HADDOCK to predict the binding affinity between SARS-CoV-2 and the ACE2 receptor affected by mutations (<xref ref-type="bibr" rid="bib38">van Zundert et al., 2016</xref>; <xref ref-type="bibr" rid="bib8">Bryant et al., 2022</xref>). Based on the pDockQ results, with Wuhan-Hu-1 as the standard, the SARS-CoV-2 variants showed strong affinity in descending order of Delta (0.577), Omicron XBB (0.575), Beta (0.569), Omicron BQ.1 (0.564), and Omicron BA.4/BA.5 (0.560) (<xref ref-type="fig" rid="fig3">Figure 3D</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Compared to the binding affinity of Wuhan-Hu-1 (0.506), the lineages with higher binding affinity were associated with infectivity (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1k–1</xref> m and <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>).</p><p>The results showed the following descending order of binding affinities for the ACE2 receptor: Delta, XBB, Beta, BQ.1, BA.4/BA.5, BA.1/BA.2, Alpha, and Wuhan-Hu-1. While Beta had a high-affinity score, it has had a low occurrence rate since its emergence, and it did not receive a high score from our evaluation model.</p><p>To check for interspecies infection in humans, bats, and pangolins, we measured the bond affinity between the virus and the host. We also measured the bond affinity of SARS-CoV-1. The bond strength of SARS-CoV-2 to the <italic>Homo sapiens</italic> ACE2 receptor is weaker than that of SARS-CoV-1 (<xref ref-type="bibr" rid="bib9">Cao et al., 2021</xref>). Although the bond strength with the same host is higher, it weakens with a different host. This suggests that viruses that evolve within a human host are likely to be the most infectious to humans. As SARS-CoV-2 evolved to Omicron, the binding affinity increased for the virus.</p><p>Overall, the Delta variant was found to be more associated with the host molecular pathway and severity. Meanwhile, the Omicron variant showed a higher interaction between the ACE2 and RBM region. The Omicron variant is more infectious.</p></sec><sec id="s2-4"><title>Development of APESS, an evaluation scoring model and, the evaluation of lineages</title><p>We developed APESS, an evaluation model to analyze viral sequences based on the nucleotide, amino acid, and protein structure properties. APESS was calculated from four previous calculations: sub-clustering of protein structure (SCPS), polarity change score (PCS), mutation rate (MR), and biochemical properties eigen score (BPES) (<xref ref-type="fig" rid="fig4">Figure 4A</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1n–q</xref> and <xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1</xref>). The detailed calculations and components of APESS are displayed in the Materials and Methods section.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>APESS: a comprehensive evaluation model of SARS-CoV-2 mutations.</title><p>(<bold>A</bold>) Amino acid property eigen selection score (APESS), an evaluation model based on the properties discovered in the receptor binding motif (RBM) and the infectivity of SARS-CoV-2, was developed. A 72-amino acid-long RBM sequence of SARS-CoV-2 was used to comprehensively evaluate the sub-clustering of protein structure (SCPS), polarity change score (PCS), mutation rate (MR), and biochemical properties eigen score (BPES). Through comprehensive analysis of each position, the infectivity of the input sequence could be evaluated against preexisting lineages. (<bold>B</bold>) The APESS scores were calculated for SARS-CoV-2 lineages Alpha, Beta, Delta, and Omicron (BA.2.75, BA.5, XBB, BQ.1), and the data were obtained for sublineages from viral sequences. The original lineages are displayed with a gray triangle and their APESS scores, whereas the sublineages are color-coded differently. The S477K substitution resulted in the highest APESS score.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig4-v2.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Amino acid property eigen selection score (APESS) evaluation of each section from variants of concerns (VOCs).</title><p>For SARS-CoV-2 lineages Wuhan-Hu-1, Alpha, Delta, Omicron (BA.4/BA.5), and Omicron (BQ.1), the sub-clustering of protein structure (SCPS), polarity change score (PCS), mutation rate (MR), and biochemical properties eigen score (BPES) scores are displayed. For SARS-CoV-2 lineages Wuhan-Hu-1, Alpha, Delta, Omicron (BA.4/BA.5), and Omicron (BQ.1), the SCPS, PCS, MR, and BPES scores were calculated. For the RBM 72 positions, a comprehensive evaluation was carried out. The colors in the figure correspond with the following: sky blue: BPES, pink: MR, khaki: PCS, orange: SCPS, and pink box: lysine (<bold>K</bold>) and arginine (<bold>R</bold>). As the lineages progressed to Omicron, SCPS, PCS, MR, and BPES scores were increased. Finally, APESS has a higher score in the most infectious lineage.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig4-figsupp1-v2.tif"/></fig><fig id="fig4s2" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 2.</label><caption><title>Amino acid property eigen selection score (APESS) distribution from viral sequences and APESS scores of variants of concerns (VOCs) from Global Initiative on Sharing All Influenza Data (GISAID).</title><p>We measured the APESS score distribution for a total of 7,335,614 sublineages. The graph was identical to the one created from the randomly selected 30,000 sublineages. We verified four components centered at 0.0236, 1.6062, 1.6404, and 2.0627. Other than the four components, density was very low. High APESS scores were observed within the low-density region, specifically for S477K and S477R mutations. In the Delta variant, amino acid substitution from Serine (<bold>S</bold>) to Arginine (<bold>R</bold>) was observed with one nucleotide change at the final codon. In the Omicron variant, amino acid substitution from Serine (<bold>S</bold>) to Lysine (<bold>K</bold>) was observed with two nucleotide changes. In other SARS-CoV-2 variants, amino acid substitution from Serine (<bold>S</bold>) to Aspartic acid (<bold>N</bold>) with one nucleotide change at the middle codon.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig4-figsupp2-v2.tif"/></fig></fig-group><p>We calculated the APESS scores of 7,335,614 viral sequences encompassing VOCs and their sublineages (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). The Alpha and Beta variants received lower APESS scores, whereas the Delta and Omicron variants (BA.5, BQ.1, and XBB) received higher scores.</p><p>We generated an APESS distribution graph for the VOC sublineages. Significant variants, including Delta and Omicron, showed APESS values higher than 1.62, indicating high infectivity (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, <xref ref-type="fig" rid="fig4s2">Figure 4—figure supplement 2</xref>). The APESS scores of the sublineages were similar to those of the VOCs. Some sublineages had lower APESS scores because of the wide variety of amino acid substitutions in the RBM region (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). The sublineages with the highest APESS scores possessed amino acid substitutions to lysine (K) and arginine (R) at S477.</p><p>APESS evaluates the infectivity of the SARS-CoV-2 lineage. Lower APESS scores indicated that the lineage is less infectious, whereas higher APESS scores indicated that it may be more infectious.</p><p>Based on cumulative prevalence results from investigations on March 21, 2023 (outbreak.info), 2% cumulative prevalence of the S477K mutation was confirmed in the Omicron variants BA.5.1 and BA.5.2. Severe infections were associated with amino acid substitutions to lysine (K) and arginine (R) at the S477 position.</p><p>Utilizing a gaussian mixture model (GMM), we divided the APESS scores of 30,000 randomly selected sublineages into four components. Four groups were identified, G1 (Alpha and Beta: a centroid at 0.0289), G2 (BA.1, BA.2.75, and XBB: a centroid at 1.9474), G3 (Delta: a centroid at 1.6383). G4 (BA.2, BA.4/5 and BQ.1: a centroid at 2.0802). We also examined the distribution for all 7,335,614 sequences and found that the results were the same as the 30,000 sampled sublineages. We observed that most of Alpha and Beta were included in the component with a centroid of 0.0289, while the component with a centroid of 2.0627 included various Omicron variants.</p></sec><sec id="s2-5"><title>Creation of candidate lineages and protein structure predictions</title><p>We introduced amino acid substitutions at specific locations in the SARS-CoV-2 backbone for the wild-type and VOCs. The amino acid substitutions were lysine (K), arginine (R), asparagine (N), serine (S), tyrosine (Y), and glycine (G). We then evaluated the infectivity of these candidate lineages with our evaluation model APESS. APESS scores of candidate lineages with amino acid substitutions to positively charged residues K and R were higher than those of the SARS-CoV-2 variants. In particular, S477K and S477R amino acid substitutions were linked to increased infectivity. In contrast, amino acid substitutions of N, S, Y, and G resulted in APESS scores similar to or lower than of the SARS-CoV-2 variants (<xref ref-type="fig" rid="fig5">Figure 5A</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Multifaceted evaluation of SARS-CoV-2: evaluation model, machine learning, and in vitro assay.</title><p>(<bold>A</bold>) Mutagenesis sequences containing consecutive hydrophilic amino acids were evaluated with amino acid property eigen selection score (APESS). They were based on Wuhan-Hu-1, Alpha, Beta, Delta, BA.1, BA.2, BA.2.75, BA.4/BA.5, XBB, and BQ.1, as indicated by colors and gray triangles. APESS values for the K, R, N, S, and Y mutated sequences of the lineages are displayed. Mutagenesis of lysine (<bold>K</bold>) and arginine (<bold>R</bold>) in Omicron sublineages resulted in increased APESS scores, whereas mutagenesis of asparagine (<bold>N</bold>), serine (<bold>S</bold>), and tyrosine (<bold>Y</bold>) resulted in decreased APESS scores. Specific regions for K and R are magnified to show the distribution of the APESS scores of the mutagenesis sequences in more detail. (<bold>B</bold>) To predict mutations with high infectivity using APESS, mutagenesis was performed using Wuhan-Hu-1, Alpha, Beta, Delta, BA.1, BA.2, BA.2.75, BA.4/BA.5, XBB, and BQ.1 as the backbone. The presence of these amino acid substitutions was verified using the viral sequence data from GISAID. For each lineage, the amino acid substitutions resulted in 280 mutagenic sequences. Thirty sequences with the highest APESS and pDockQ scores are displayed. N460R and S469R have not been observed naturally, whereas N439R, S459R, N437R, Y501R, S438R, and S494R have been observed in ten people or less. (<bold>C</bold>) For mutations occurring in lineages and mutations evaluated through APESS, AI learning models (Random Forest, LightGBM, XGBoost, Ensemble, and deep learning) were used to investigate the probability. For N460K, there was a ninefold increase in the probability of XBB compared to prior Omicron lineages. Q493R is not found in XBB but still has a high probability of occurrence. (<bold>D</bold>) The effects of N437 and N460 amino acid substitutions on viral infection were evaluated in vitro using luciferase and viral entry assays. There was a significant increase in the Relative Light Units and viral entry percentage for N437R, and vice versa for N460K.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Prediction results of notable mutations in SARS-CoV-2 using ML/DL.</title><p>For mutations occurring in SARS-CoV-2 lineages (N440K, V445P, G446S, N460K, S477N, T478K, E484A, F486P, F490S, Q498R, N501Y, Y505H, L452R, E484K, Q493R, G496S, F486V, K444T) and mutations evaluated through APESS (N477R, N477K, N439R, Y501R, N437R, S438R, S459R, S469R, S494R, T470R, T500R, Q493K, T470K, T500K, S469K, S494K, Y501K, N437K, N439K, N460R, S438K, S459K, N460K, Q493R), artificial intelligence learning models were used to evaluate probability. LightGBM, XGBoost, Ensemble, and deep learning methods showed similar results to Random Forest.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Protein structure evaluation of D467.</title><p>Close-up views of the mutated receptor binding domain (RBD) residues and their adjacent residues. ACE2 and RBD are color-coded in wheat and silver cartoons, while the original and mutated RBD residues are represented as white and magenta sticks. Mutagenesis was carried out using PyMol, and all figure images were constructed using ChimeraX-1.5.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Binding affinity measurement of N460K and Q493R receptor binding domain (RBD) variants.</title><p>Surface plasmon resonance results show binding affinity between RBD wild-type (<bold>A</bold>), N460K (<bold>B</bold>), and Q493 (<bold>C</bold>) toward human ACE2. The hACE2 protein was used as a ligand and all experiments were conducted on the same sensor chip.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig5-figsupp3-v2.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 4.</label><caption><title>Flowchart for predicting mutation occurrences using artificial intelligence.</title><p>We used machine learning and deep learning methods to predict the likelihood of mutations occurring. ① We began by filtering the information and samples from the Global Initiative on Sharing All Influenza Data (GISAID) data. Unnecessary samples were removed depending on the presence of nonsense mutations, the host species, and the data format of the date column. Then, target mutations in the receptor binding motif (RBM) region were converted into binary variables. Finally, filtering is completed by removing unused features and samples with missing data, excluding the clade, date, and binary target mutation columns. ② In order to utilize the filtered data for training, we preprocessed the data. We replaced the date information in the YYYY-MM-DD format with integer values indicating how many days had passed since the earliest recorded date, 2019-12-23. Then, the values were normalized to [0–1]. We then created preprocessed data by one-hot encoding the clade data. ③ We created a training model and then used the trained model to predict the likelihood of the target mutations. Five different training models were involved in this process. ③–1 A prediction model using LightGBM, ③–2 a model using XGBoost, ③–3 sklearn library’s Random Forest model, and then an ensemble model of the previous three models were used. Finally, ③–4 keras was used to create a multi-output neural network model for training and predicting the likelihood of the target mutations.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig5-figsupp4-v2.tif"/></fig></fig-group><p>Of the mutated sequences, amino acid substitutions of K and R showed the highest APESS and pDockQ scores (<xref ref-type="fig" rid="fig5">Figure 5B</xref>).</p><p>We used deep learning and machine learning methods to determine the probability of amino acid substitutions at specific locations in the lineages before and after the Omicron variant emergence. Models such as random forest, light-gradient boosting machine (LightGBM), extreme Gradient Boosting (XGBoost), and ensemble methods were used, and consistent results were obtained (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1r–1</xref> v). Specifically, for N460K, we found that the probability increased as the lineage progressed to Omicron. For Q493R, the probability was relatively constant for Omicron lineages (<xref ref-type="fig" rid="fig5">Figure 5C</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1w</xref>). We used Accuracy, Precision, Recall, and F1 score to evaluate performance. All models showed high-performance scores above 0.95 in Precision, Recall, and F1 score. For accuracy, XGBoost, scored above 0.89, exhibiting relatively high performance while LightGBM scored above 0.78.</p><p>To validate the binding kinetics of Q493R and N460K variant RBDs to human ACE2 at the macromolecular level, we performed surface plasmon resonance (SPR). In line with our computational prediction, both variants show approximately a threefold increase in binding affinity compared to the wild-type RBD (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplements 2</xref> and <xref ref-type="fig" rid="fig5s3">3</xref>).</p><p>We further verified the infectivity of the predicted mutations using luciferase and viral entry assays (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). N437R mutation led to a twofold increase in luciferase activity and viral entry compared to the wild-type (spike protein D614G). In contrast, N460K and Q493R mutations led to a decrease in luciferase activity and viral entry compared to the wild-type (spike protein D614G) (<xref ref-type="fig" rid="fig5">Figure 5D</xref>, <xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). However, the viral entry of N460K was 10-fold higher than that of Q493R. N460K mutations occurred at a low rate but had a higher probability of infection compared to other mutations.</p><p>Therefore, our results imply that the maintenance of the proliferative rate of the virus was due to new mutations, high docking scores, and an increased presence of Omicron variants (<xref ref-type="fig" rid="fig3s3">Figure 3—figure supplements 3</xref>–<xref ref-type="fig" rid="fig3s12">12</xref>).</p><p>Based on our findings, we developed AIVE (<ext-link ext-link-type="uri" xlink:href="https://ai-ve.org/">https://ai-ve.org/</ext-link>), a web-based platform enabling rapid and precise prediction of protein structure and calculation of SARS-CoV-2 infectivity. AIVE facilitates the analysis of virus sequences entered by users and provides visualization and analysis reports, allowing it to be used in environments without GPU installation (<xref ref-type="fig" rid="fig6">Figure 6</xref>). For example, we used a customized sequence wherein N460K substitution was introduced into the Wuhan-Hu-1 sequence (Wuhan-Hu-1+N460 K) as an input. The output generated the following four results:</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Prediction of potential SARS-CoV-2 mutations through integrated evaluation and prediction.</title><p>(Input). This figure consists of three steps: ‘Input,’ ‘Processing,’ and ‘Output.’ Users can select a custom sequence from the entire SARS-CoV-2 sequence, choose variants of concerns (VOCs), or create customized sequences for analysis. Depending on the user’s system environment, analysis can be done through local prediction (server) or Google Colab. (Processing) Three types of analyses are performed. First, the protein 3D structure prediction is analyzed. This includes protein 3D structure, predicted local distance difference test (pLDDT), and predicted aligned error (PAE). Second, the infectivity is evaluated using APESS (2.12). For each position, the structural difference graph for biochemical properties eigen score (BPES), mutation rate (MR), polarity change score (PCS), and sub-clustering of protein structure (SCPS) is visualized. The APESS distribution is visualized for known VOCs and created variants. Third, polarity changes are visualized in sequences. (Output) Four results comparing Wuhan-Hu-1+N460 K and XBB (with N460K) are output and visualized. First, through protein structure prediction, secondary structures can be confirmed in XBB (with N460K) compared to Wuhan-Hu-1+N460 K (Yellow arrow). Second, the comparison of polarity changes through the mutation of Wuhan-Hu-1+N460 K (red dotted line) is done. Third, in XBB (with N460K), which has more mutations than Wuhan-Hu-1+N460 K, the difference in values at each position in the protein sequence of SCPS, PCS, MR, and BPES is displayed (red dotted line). Fourth, the distribution of APESS, which represents the comprehensive value of SCPS, PCS, MR, and BPES, is shown. ‘apess’ indicates the score for each position in the customized protein sequence. In the case of XBB (with N460K), which has more mutations than Wuhan-Hu-1+N460 K, an apess score distribution of XBB (with N460K) has values from –0.079–1.385 is shown (Yellow arrow). X-axis presents the position in RBM (72aa) and Y-axis presents APESS score, respectively (④–1). APESS is the summed value of each position and can evaluate infectivity. A region including XBB (with N460K) shows infectivity due to many mutations, and also shows an increase in APESS score due to the N460K mutation. X-axis presents APESS score and Y-axis presents a density, respectively (④–2). AIVE comprehensively evaluates viral infectivity, protein structure, amino acid substitutions, and polarity changes in preexisting and potential SARS-CoV-2 sequences.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig6-v2.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>The user interface user experience (UI/UX) of the AIVE system.</title><p>An instruction manual for accessing the AIVE website (<ext-link ext-link-type="uri" xlink:href="https://ai-ve.org/">ai-ve.org</ext-link>) and using its prediction was shown. ① The project name is entered by the user. ② The target virus is selected. In the demonstration, SARS-CoV-2 is selected. ③ The specific variant of concern (VOC) can be selected. In the demonstration, Wuhan-Hu-1 is selected. ④ Click on the receptor binding domain (RBD) region. ⑤ The amino acid can be selected in the position in the sequence. ⑥ The codon can be selected for the amino acid. ⑦ Server prediction is started. ⑧ For Prediction List, it shows the current job list with ongoing projects and how much time is left for analysis. ⑨ The 3D Structure Prediction results are shown. ⑩–1 The 3D Protein structure (SARS-CoV-2, Reference) ⑩–2 The 3D Protein structure (Mutation). ⑩–3 The Predicted LDDT score. ⑪ Scores of sub-clustering of protein structure (SCPS), polarity change score (PCS), mutation rate (MR), and biochemical properties eigen score (BPES) by amino acid position. ⑫ Scores of amino acid property eigen selection score (APESS) by amino acid position. ⑬ Distribution of APESS score of SARS-CoV-2 VOCs Alpha, Beta, Delta, and Omicron (BA.2.75, BA.5, XBB, BQ.1) and location of APESS range as the input. ⑭ Comparison of polarity change between input and reference. ⑭–1. Number of NN*, NP*, NA*, NB*, PN*, PP*, PA*, PB*, AN*, AP*, AA*, AB*, BN*, BP*, BA*, BB* between input and reference.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig6-figsupp1-v2.tif"/></fig><fig id="fig6s2" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 2.</label><caption><title>Frequencies of amino acid substitutions of major variants within clades.</title><p>Phylogenetic tree showing the evolution of SARS-CoV-2 lineages and their sub-lineages. Before Omicron, at various positions N440, L452, T478, T484, Q493, Q498, N501, Y505, the frequency of amino acids is displayed. There are different types of amino acid substitutions present with the different positions showing varied percentages. In Omicron lineages, the frequency of amino acid substitutions of N440K, L452R, T478K, T484A, Q493R, Q498R, N501Y, and Y505H approach 100%, showing that amino acid substitutions become fixed.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-fig6-figsupp2-v2.tif"/></fig></fig-group><p>First, protein structure prediction results showed that Wuhan-Hu-1+N460 K had increased folding compared to Wuhan-Hu-1. Meanwhile, XBB, which contains N460K substitution, demonstrated a more stabilized protein structure compared to Wuhan-Hu-1+N460 K due to the alpha-helix in the 493–495 region and the beta-sheet in the 465–467 and 505–507 regions (Panel ① of <xref ref-type="fig" rid="fig6">Figure 6</xref>). Second, for polarity changes, there was a decrease in consecutive hydrophilic amino acids in Wuhan-Hu-1+N460 K due to the mutation (Panel ② of <xref ref-type="fig" rid="fig6">Figure 6</xref>). Third, calculations of the APESS sub-scores showed a difference in scores for XBB compared to Wuhan Hu-1 +N460 K owing to mutations (Panel ③ of <xref ref-type="fig" rid="fig6">Figure 6</xref>). Fourth, the APESS distribution was displayed as ‘apess,’ which reflects the score at each position in the amino acid sequence. The apess score at N460K for both Wuhan-Hu-1+N460 K and XBB (with N460K) was 0.112 (Panel ④–1 of <xref ref-type="fig" rid="fig6">Figure 6</xref>). Furthermore, the distribution of the total ‘APESS’ score, which comprehensively evaluates each position of the sequencing results, was used to determine the infectivity sections. Usage guidelines of AIVE can be found in supplementary information (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>).</p><p>An apess score at N460K for XBB (with N460K) was 1.967. XBB (with N460K) mutation was located in the infectivity region with a statistically significant association (&gt;95%, pink color), whereas APESS score increased for Wuhan Hu-1 +N460 K compared to Wuhan Hu-1 but was not included in the high infectivity section containing XBB (Panel ④–2 of <xref ref-type="fig" rid="fig6">Figure 6</xref>). Therefore, our research findings enable rapid protein structure prediction and APESS via meticulous and systematic structuring of data. Visualization of these analyses and the evaluation of infectivity are available on AIVE.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we aimed to comprehensively analyze the viral sequence and protein structure of SARS-CoV-2 and investigated its association with epidemiological data. Specifically, we analyzed the impact of these factors on infection and predicted the occurrence of new mutations. Our approach involved a multistep analysis. First, we identified specific amino acid substitutions within the viral genome, focusing on their potential impact on SARS-CoV-2 protein structure. Second, we explored the impact of these structural changes on the interaction between SARS-CoV-2 and the host. Third, we assessed the potential effects of these changes on virus infectivity. This systematic analysis allowed us to gain useful insights into the behavior and evolution of the virus.</p><p>Hydrophobic protein structure plays an important role in protein stability and folding (<xref ref-type="bibr" rid="bib26">Pace et al., 2011</xref>; <xref ref-type="bibr" rid="bib17">Islam et al., 2019</xref>). This affects structural changes from hydrophilic to hydrophobic or positively charged residues.</p><p>In our investigation of various viruses, Flaviviruses, including Zika virus, Japanese encephalitis virus, and Dengue virus, are enveloped viruses that use envelope proteins to infiltrate the host. Infection is facilitated by E-protein folding, which causes the virus to fuse with its host (<xref ref-type="bibr" rid="bib16">Hu et al., 2021</xref>). Recently, SARS-CoV-2 treatments targeted the folding of the nonstructural protein NSP3 of the virus (<xref ref-type="bibr" rid="bib4">Bergasa-Caceres and Rabitz, 2020</xref>). Research on avian coronaviruses has shown that the introduction of a hydrophobic domain into the infectious bronchitis virus E protein affects the infectivity of the virus (<xref ref-type="bibr" rid="bib30">Ruch and Machamer, 2011</xref>). Amino acid substitutions such as L411F, F472S, D510S, and I529T have been reported in MERS-CoV (<xref ref-type="bibr" rid="bib39">Wong et al., 2021</xref>; <xref ref-type="bibr" rid="bib23">Kleine-Weber et al., 2019</xref>). In addition to D510S, consecutive hydrophilic amino acids were observed in MERS-CoV, which we believe contributed to its low infectivity (<xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>).</p><p>Our analysis primarily focused on the RBM (amino acids 437–508) region of the spike protein of SARS-CoV-2 that directly interacts with the ACE2 receptor, allowing the virus to infiltrate host cells and discover mutations in VOCs and VUMs. In the Alpha, Beta, and Delta lineages, specific amino acid substitutions occurred in various locations. For Omicron, less diversity was observed for amino acid substitutions (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>Amino acid substitutions became fixed as SARS-CoV-2 lineages progressed. Examination of epidemiological data revealed four distinct periods. During the first and third periods, there was less diversity in amino acid substitutions, leading to a decrease in both infections and deaths (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). In contrast, during the second period, there was more diversity in amino acid substitutions for the sublineages, leading to an increased number of cases and deaths. Thus, we established an association between the fixation of SARS-CoV-2 amino acid substitutions and infectivity.</p><p>We made discoveries on specific amino acid substitutions at positions. The N437R mutation led to increased viral infectivity and received a high APESS score but was barely observed in patients. We detected only three instances of N437R amino acid substitutions, all with the AAT codon, where two or more codon positions must undergo alterations. Such changes were only in V445P, a mutation found in XBB and its sublineages, but it occurred at a miniscule rate of 0.14%. Although not yet prominent, N437R is expected to be associated with high infectivity and remains a primary candidate for close monitoring in the future.</p><p>Frequency prediction of N460K through machine learning showed a ninefold increase compared to BA.1. And the mutation showed decreased viral entry in vitro and low binding affinity in silico. The N460K mutation affects docking but combination with other mutations could increase infectivity. Ito et al. confirmed that N460K mutation forms a hydrogen bond to N-linked glycan on N90 of human ACE2 (<xref ref-type="bibr" rid="bib18">Ito et al., 2023</xref>).</p><p>The D467 position plays a key role in a salt-bridge interaction within the Delta variant (<xref ref-type="bibr" rid="bib3">Baral et al., 2021</xref>). Due to this and mutations at the position being extremely rare suggest that D467 contributes to the structural stability of the virus. Specifically, amino acid substitutions D467P and D467I disrupt the salt bridge formed by R457 and R454 (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Salt bridges play an important role in thermostabilization (<xref ref-type="bibr" rid="bib2">Ban et al., 2019</xref>) and represent electrostatic interactions between positively charged and negatively charged residues. Alterations in positively charged residues can disrupt these salt-bridge interactions with negatively charged residues of SARS-CoV-2. Overall, mutations at this site impair the ability of SARS-CoV-2 to effectively infect the host. In silico results showed amino acid substitutions at D467 caused the alpha helix to present in the wild-type to change into a linear structure (<xref ref-type="fig" rid="fig2s3">Figure 2—figure supplement 3</xref>).</p><p>XBB predicted by ML exhibited a decrease in frequency, displaying a low slope and signifying slow disappearance (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). Protein measurement proved to be difficult in vitro. Notably, there was an approximately twofold increase in binding affinity against the wild-type in SPR analysis. For the Q493R mutation itself, the docking is low but combined with other mutations, it showed increased docking. We believe that the mutation itself negatively affects the spike protein structure but is important in binding with the host overall. Recent structural research which identified RBD-ACE2 complex structures of BQ1.1 (N460K) and B1.1.529 (Q493R) supports our results (<xref ref-type="bibr" rid="bib13">Han et al., 2022</xref>).</p><p>Our research shows that consecutive hydrophobic amino acids in the RBM region and specific amino acid substitutions affect not only infection but also protein structure. We assessed the infectivity of SARS-CoV-2 lineages using protein structure prediction. We observed that the emergence of various mutations corresponded to changes in binding affinity. As SARS-CoV-2 lineages progressed to Omicron, their binding affinity became stronger, resulting in increased infectivity, notably in the Delta and Omicron variants. Conversely, the Beta variant showed high binding affinity but not high infectivity. Our assumption is that for consecutive amino acids and amino acid substitutions, lysine (K) and arginine (R) have less weight; therefore, Beta is unlikely to develop into a significant variant. We speculate that the Beta variant emerged early in the pandemic, potentially limiting its ability to infect a large population, while widespread vaccination efforts may have contributed to decreased infectivity.</p><p>During the evolutionary process of SARS-CoV-2, the increase in infectivity and severity of variants from Alpha to Delta was attributed to abnormalities in the molecular signaling systems of the host. In contrast, Omicron showed lower severity but increased infectivity. We believe this is because of structural changes that allow the variant to bind well with the ACE2 receptor (<xref ref-type="fig" rid="fig3">Figure 3</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). In addition, epidemiological data reveals a decrease in deaths, the reproduction rate is maintained, and Omicron has high docking which confirms the high infectivity. We created mutagenesis sequences created from the backbone of Wuhan-Hu-1 and VOCs with amino acid substitutions to lysine (K) and arginine (R). Sequences from the backbone of Omicron XBB were predicted to have high infectivity and still liable to occur. We can therefore expect consistent infections caused by SARS-CoV-2 going forward.</p><p>We comprehensively evaluated genomic and epidemiological data. This multifaceted approach, along with the usage of APESS, machine learning, in vitro assays, and AIVE ensured a more comprehensive understanding of SARS-CoV-2 behavior and evolution. In addition, by applying GMM to the APESS score of a new sample, we can predict its membership within a specific component (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). This prediction allows us to make informed conjectures about its potential strains and infectivity.</p><p>Based on our findings, we predicted approximately 440 mutations with a probability of occurring in the near future. One year after generating the predicted datasets, BA.2.86, EG.5.1, and HK.3 were included in the datasets and were reported to the highest frequencies with 43%, 28%, and 12% at Nextstrain (<ext-link ext-link-type="uri" xlink:href="https://nextstrain.org/ncov/gisaid/global/6m">https://nextstrain.org/ncov/gisaid/global/6m</ext-link>; December 21, 2023). APESS values of them also were high at 2.051, 1.982, and 1.986, respectively. These mutations were provided in AIVE and can be considered as important targets to prevent a new wave of infections.</p><p>We created AIVE to feature our findings and analyses on an online platform. AIVE can be easily utilized without expert knowledge of its algorithm and its analysis features can be used without GPU setup or the need for software library installations. Furthermore, AIVE offers a user-friendly interface with the flexibility to input and append experiment data for analysis. Additionally, ongoing and past analyses can be accessed after processing, providing many options for management. The time required for analysis in the local server or Google Colab can be verified. The local server run on RTX8000 takes 50 min, offers a large database, and is free to use (<xref ref-type="fig" rid="fig6">Figure 6</xref>). After completing the job, the user can examine and manage the analysis results permanently with their account generated on AIVE.</p><p>Prior research of SARS-CoV-2 included analysis of epidemiological data, molecular work, and AI applications. We adopted a comprehensive approach, utilizing real-world data and multi-faceted validation. Our research reveals that SARS-CoV-2 increased in infectivity over time, illuminating significant trends in viral infections. Our discoveries, evaluation model, and the AIVE platform will serve as the foundation for preparedness against further developments in future pandemics.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Data collection</title><p>We used the World Health Organization tracking of SARS-CoV-2 variants to verify the currently circulating VOCs. In the tracking SARS-CoV-2 variants page, variants are divided into currently circulating VOCs, currently circulating variants of interest (VOIs), and currently circulating VUMs. In our study, the primary currently circulating VOCs were Omicron, including BA.1, BA.2, BA.3, BA.4, and BA.5 (<ext-link ext-link-type="uri" xlink:href="https://www.who.int/activities/tracking-SARS-CoV-2-variants">https://www.who.int/activities/tracking-SARS-CoV-2-variants</ext-link>).</p><p>To obtain the precise lineage and mutation data, <ext-link ext-link-type="uri" xlink:href="https://cov-lineages.org/">cov-lineages.org</ext-link> and <ext-link ext-link-type="uri" xlink:href="https://outbreak.info/">outbreak.info</ext-link> databases were used. For the sublineage analysis of the viral sequences collected through GISAID, we used accurately defined sublineage information from the outbreak.info platform.</p><p>Using WHO VOCs as standards, Alpha (B.1.1.7), Beta (B.1.351), Delta (B.1.617.2), and Omicron (BA.1, BA.2, and BA.4/BA.5) were selected as the main lineages. From WHO’s currently circulating VUMs as of 17 May 2023, we included Omicron BA.2.75 nicknamed ‘Centaurus,’ BQ.1, and XBB.</p><p>We downloaded the mutation data of the currently reported 7,335,614 viral sequences from GISAID and utilized the data for the following purposes: first, the epidemiological data were categorized based on the patient status column: symptomatic or asymptomatic, and severity: mild or severe (including hospitalized and deceased). Second, for VOCs, including sublineages, we categorized lineage, date, and mutations in the RBM region. Third, to utilize the learning data, we categorized clades, lineages, and mutations in the RBM region. Our epidemiological data on COVID-19 used our world’s data (OWID, <ext-link ext-link-type="uri" xlink:href="https://ourworldindata.org/">https://ourworldindata.org/</ext-link>). For confirmed cases and deaths, we used 7 d rolling average worldwide data. For vaccine doses, cumulative vaccine doses were used.</p></sec><sec id="s4-2"><title>Detection of amino acid features from SARS-CoV-2 sequences</title><p>We defined four properties: hydrophilicity (polar, P), hydrophobicity (non-polar, N), alkalinity (basic, B), and acidity (A). We divided two consecutive positions of amino acids with these properties into NN*, NP*, NA*, NB*, PN*, PP*, PA*, PB*, AN*, AP*, AA*, AB*, BN*, BP*, BA*, and BB*, with the most common combination being NN*, NP*, PN*, and PP*.</p><p>We verified consecutive amino acids in the SARS-CoV-2 viral sequence spike protein. First, we categorized alanine (A), valine (V), leucine (L), glycine (G), isoleucine (I), methionine (M), tryptophan (W), phenylalanine (F), and proline (P) as hydrophobic amino acids. Second, we categorized serine (S), cysteine (C), asparagine (N), glutamine (Q), threonine (T), and tyrosine (Y) as hydrophilic amino acids. Third, lysine (K), arginine (R), and histidine (H) were categorized as alkaline amino acids (B: positively charged). Finally, aspartic acid (D) and glutamic acid were categorized as acidic amino acids.</p><p>We performed the following analysis to observe the polarity changes due to specific amino acid substitutions. Based on polarity and considering the possibility of mutations occurring, we classified each adjacent amino acid for each mutation and divided them into 64 patterns of three amino acids grouped together. We determined the pattern changes caused by the mutations. The analysis methods are available publicly on the web-based platform AIVE (<ext-link ext-link-type="uri" xlink:href="https://xn--aive-186a.org/">https://xn--aive-186a.org/</ext-link>) and GitHub (<ext-link ext-link-type="uri" xlink:href="https://github.com/Honglab-Research/AIVE">https://github.com/Honglab-Research/AIVE</ext-link>, copy archived at <xref ref-type="bibr" rid="bib14">Honglab-Research, 2023</xref>).</p></sec><sec id="s4-3"><title>Protein 3D structure evaluation</title><p>We utilized Alphafold2 to measure protein structure folding and used pDockQ and HADDock to measure the binding affinity between SARS-CoV-2 and the ACE2 receptor (<xref ref-type="bibr" rid="bib21">Khan and Ranganathan, 2010</xref>). We used AlphaFold2 to predict changes in the 3D structure of the RBM at amino acid positions 437–508 in the SARS-CoV-2 viral sequence. We performed predictions for Wuhan-Hu-1, Alpha, Beta, Delta, and Omicron (BA.1, BA.2, BA2.75, BA.4, BA.5, XBB, and BQ.1).</p><p>Through UniProt (P0DTC2 · SPIKE_SARS2), we used the viral sequence in the RBM region ‘NSNNLDSKVGGNYNYLYRLFRKSNLKPFERDISTEIYQAGSTPCNGVEGFNCYFPLQSYGFQPTNGVGYQPY.’ We performed an analysis using mutation data per lineage (<ext-link ext-link-type="uri" xlink:href="https://www.uniprot.org/uniprotkb/P0DTC2/entry">https://www.uniprot.org/uniprotkb/P0DTC2/entry</ext-link>).</p><p>We used AlphaFold2 and through structure predictions, we observed structural similarity, distance, and folding between amino acids. The predicted local distance difference test (pLDDT), Predicted Aligned Error (PAE), and AlphaFold2 results were used for analysis. Additionally, protein data bank (PDB) files and another AlphaFold2 result, were used to visualize the 3D structures using ChimeraX (<xref ref-type="bibr" rid="bib29">Pettersen et al., 2021</xref>). We measured the binding affinity between the human ACE2 receptor and the SARS-CoV-2 RBM region. We obtained the human ACE2 receptor sequence from UniProt (UniProt: Q9BYF1).</p><p>To increase the confidence of binding affinity analysis, first, we used pDockQ to score binding affinity. Second, we used HADDOCK 2.2 for analysis and comprehensively evaluated the HADDOCK score, root mean square deviation (RMSD), van der Waals energy, electrostatic energy, and desolvation energy (<xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). AIVE can predict the structural features of SARS-CoV-2 in different regions and the binding affinity between the human ACE2 receptor and the RBM region of SARS-CoV-2.</p></sec><sec id="s4-4"><title>Analysis of the association between epidemiology and mutations</title><p>From 7,335,614 viral sequences sourced from GISAID, we identified mutations commonly discovered in VOCs and VUMs: L440K, K444T, L452R, N460K, S477N, T478K, E484A, F486V, Q498R, and Y501H. We measured the odds ratios for mutations commonly discovered in VOCs and VUMs: L440K, K444T, L452R, N460K, S477N, T478K, E484A, F486V, Q498R, and Y501H, and epidemiological indicators (symptomatic/asymptomatic and mild/severe). These analyses were performed using the traditional statistical method of logistic regression.</p><p>In the patient status column of the data file, we used asymptomatic and symptomatic rows. Deceased, hospitalized, and severe patients were categorized as severe, while outpatients, not hospitalized, and mild were categorized as mild. R version 4.1.1 and python 3.9.13 were used in our analysis.</p></sec><sec id="s4-5"><title>Evaluation of SARS-CoV-2 mutation infectivity through evaluation modeling</title><p>We developed an evaluation model to comprehensively evaluate SARS-CoV-2 at the RNA, amino acid, and protein structure levels. SCPS, PCS, MR, and BPES were designed and calculated for each variant.</p></sec><sec id="s4-6"><title>SCPS</title><p>To better understand the molecular structure of SARS-CoV-2 lineages, we used the PAE, pLDDT, pdb, and hydrogen bonds that caused abnormal physical and chemical properties of the compounds to proceed with clustering.</p><p>Using clustering, the SARS-CoV-2 lineages were divided into six clusters, and the main variants were mostly observed in the first and third clusters. For the cluster distribution for each lineage, ‘cluster 2’ showed the largest difference in folding compared to the Wuhan-Hu-1 variant, and the lowest difference in folding compared to the Delta and Omicron (BA.4/BA.5) variants. Meanwhile, ‘cluster 4’ contained the lineages with the most extreme folding showed a relaxation of folding in the main variants.</p><p>Based on this analysis, protein structure prediction-based clustering was defined as follows:<disp-formula id="equ1"><mml:math id="m1"><mml:mrow><mml:mrow><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">C</mml:mi><mml:mi mathvariant="normal">P</mml:mi><mml:msub><mml:mi mathvariant="normal">S</mml:mi><mml:mi mathvariant="normal">i</mml:mi></mml:msub></mml:mrow><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:mrow><mml:mn>0.9</mml:mn><mml:mspace width="thinmathspace"/><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>S</mml:mi><mml:mi>C</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">T</mml:mi><mml:mn>4</mml:mn></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>0.1</mml:mn><mml:mspace width="thinmathspace"/><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>S</mml:mi><mml:mi>C</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mrow><mml:mi mathvariant="normal">T</mml:mi><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">T</mml:mi><mml:mn>3</mml:mn><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">T</mml:mi><mml:mn>5</mml:mn><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">T</mml:mi><mml:mn>6</mml:mn></mml:mrow><mml:mo>}</mml:mo></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>where T1 is cluster 1 (437–449), T2 is cluster 2 (450-460), T3 is cluster 3 (461-471), T4 is cluster 4 (472-479, 501-508), T5 is cluster 5 (480-489), and T6 is cluster 6 (490-500), which are positioned in the RBM of the RBD.</p><p>Omicron and Delta variants take up 88.3% of the 7,335,614 viral sequences from GISAID. Therefore, we applied a weight of 0.9 to the T2 and T4 clusters and 0.1 to the remaining clusters.</p></sec><sec id="s4-7"><title>PCS</title><p>To calculate the amino acid substitutions in the RBM sequence, we counted each lineage: Wuhan-Hu-1, Alpha, Beta, Delta, and Omicron (BA.1, BA.2, BA2.75, BA.4, BA.5, BQ.1, and XBB). For the counting method, we started from the beginning of the RBM, sliding three positions after each count until the final 72<sup>nd</sup> position was reached.<disp-formula id="equ2"><mml:math id="m2"><mml:mrow><mml:mi>P</mml:mi><mml:mi>C</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo>{</mml:mo><mml:mtable rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:mrow><mml:mn>0.9</mml:mn><mml:mspace width="thinmathspace"/><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>P</mml:mi><mml:mi>C</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>∈</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>P</mml:mi><mml:msup><mml:mi>P</mml:mi><mml:mo>∗</mml:mo></mml:msup><mml:mi mathvariant="normal">Λ</mml:mi><mml:mi>P</mml:mi><mml:mi>C</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>∉</mml:mo><mml:mi>P</mml:mi><mml:msup><mml:mi>P</mml:mi><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>0.5</mml:mn><mml:mspace width="thinmathspace"/><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>P</mml:mi><mml:mi>C</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>∈</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>P</mml:mi><mml:msup><mml:mi>P</mml:mi><mml:mo>∗</mml:mo></mml:msup><mml:mi mathvariant="normal">Λ</mml:mi><mml:mi>P</mml:mi><mml:mi>C</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>∉</mml:mo><mml:mi>P</mml:mi><mml:msup><mml:mi>P</mml:mi><mml:mo>∗</mml:mo></mml:msup></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mn>0.1</mml:mn><mml:mspace width="thinmathspace"/><mml:mi>i</mml:mi><mml:mi>f</mml:mi><mml:mspace width="thinmathspace"/><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>h</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mi>w</mml:mi><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable><mml:mo fence="true" stretchy="true" symmetric="true"/></mml:mrow></mml:mrow></mml:math></disp-formula><disp-formula id="equ3"><mml:math id="m3"><mml:mrow><mml:mi>P</mml:mi><mml:msup><mml:mi>P</mml:mi><mml:mo>∗</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:mrow><mml:mo>[</mml:mo><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>a</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:msub><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:msub><mml:mi>a</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mrow><mml:mo stretchy="false">|</mml:mo></mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:msub><mml:mi>a</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:mo>∈</mml:mo><mml:mi>P</mml:mi><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:msub><mml:mi>a</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>∉</mml:mo><mml:mi>P</mml:mi></mml:mrow><mml:mo>]</mml:mo></mml:mrow><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mrow><mml:mi mathvariant="normal">P</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">y</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mi mathvariant="normal">r</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mi mathvariant="normal">p</mml:mi><mml:mi mathvariant="normal">h</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">l</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">s</mml:mi><mml:mi mathvariant="normal">e</mml:mi><mml:mi mathvariant="normal">t</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">d</mml:mi><mml:mspace width="thinmathspace"/><mml:msub><mml:mi mathvariant="normal">a</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">s</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">n</mml:mi><mml:mi mathvariant="normal">o</mml:mi><mml:mspace width="thinmathspace"/><mml:mi mathvariant="normal">a</mml:mi><mml:mi mathvariant="normal">c</mml:mi><mml:mi mathvariant="normal">i</mml:mi><mml:mi mathvariant="normal">d</mml:mi></mml:mrow></mml:mrow></mml:math></disp-formula></p><p>Three consecutive amino acids with two hydrophilic amino acids in Wuhan-Hu-1 changes due to mutation (0.9), when the inverse occurs (0.5), and for mutations unrelated to consecutive hydrophilic amino acids (0.1).</p></sec><sec id="s4-8"><title>MR</title><p>Based on the base trans rate and codon compositional bias, we investigated the ratio of A, T, G, and C in SARS-CoV-2 spike protein nucleotides and calculated the rate of change of bases depending on the mutations occurring. On average, the SARS-CoV-2 virus comprises 30.2% A, 19.9% G, 32.4% U, and 17.6% C. For 17 lineages {Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), Zeta (P.2), Epsilon (B.1.427), Epsilon (B.1.429), Eta (B.1.525), Lambda (C.37), Mu (B.1.621), Omicron (BA.1), Omicron (BA.2), Omicron (BA.4), Omicron (BA.5), Omicron (BA.2.75), Omicron (BQ.1), and Omicron (XBB)}, we checked the differences between the codon positions where mutations occurred. We set the first codon at 28%, second codon at 49%, and the third codon at 22% to create an amino acid mutation property equation based on biological properties.<disp-formula id="equ4"><mml:math id="m4"><mml:mrow><mml:mi>M</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>m</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>−</mml:mo><mml:mi>m</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>m</mml:mi><mml:mi>r</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac><mml:mspace width="thinmathspace"/><mml:mspace width="thinmathspace"/><mml:mspace width="thinmathspace"/><mml:mrow><mml:mi mathvariant="normal">m</mml:mi><mml:mi mathvariant="normal">r</mml:mi></mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∏</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mn>3</mml:mn></mml:mrow></mml:munderover><mml:msub><mml:mrow><mml:mi mathvariant="normal">N</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>×</mml:mo><mml:msub><mml:mrow><mml:mi mathvariant="normal">C</mml:mi></mml:mrow><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:math></disp-formula></p><p>For each codon position, MR<sub>i</sub> (w,m) calculates the frequency of mutation (m) against the reference (w). mr(x) evaluates the frequency change for each nucleotide in a codon. N<sub>j</sub>(x) is the frequency for j-the nucleotide. C<sub>j</sub>(x) is the frequency for j-the codon position: C<sub>1</sub> (first codon 28%), C<sub>2</sub> (second codon 49%), and C<sub>3</sub> (third codon 22%).</p><p>The total mutation rate interval is [0.0072, 0.0201] for 64 codons. 16 amino acids (G, E, A, V, R, K, N, T, I, Q, H, L, W, C, Y, and S) are amino acid substitutions that occur in SARS-CoV-2. The mutation rate interval for these amino acid substitutions is [0.0115, 0.0137].</p></sec><sec id="s4-9"><title>BPES</title><p>We used amino acid properties such as residue, pH, and hydrophobic properties using principal component analysis (PCA). From VOCs, we analyzed the 72 amino acids included in the RBM region. Regarding amino acid properties, amino acids with residues C, D, E, K, R, and Y were in the order R:12.48, K:10.53, and Y:10.07. pH was in the order of R:10.76, K:9.74, and H:7.59. The hydrophobic amino acids were in the order of R: –4.5 and K: –3.9, where K and R showed similarly high scores. K and R received high scores for all the three amino acid properties (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1x</xref>). Based on the three biochemical properties of amino acids (residue, pH, and hydrophobicity) and the PCA clustering, we defined the eigenscore as follows.<disp-formula id="equ5"><mml:math id="m5"><mml:mrow><mml:mtable columnalign="left left" rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mo>,</mml:mo><mml:mspace width="thinmathspace"/><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>b</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mo>−</mml:mo><mml:mi>b</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>m</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mi>b</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>w</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mfrac></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mi>b</mml:mi><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:mrow><mml:mo symmetric="true">‖</mml:mo><mml:mrow><mml:mi>R</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo symmetric="true">‖</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mi>R</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>⋅</mml:mo><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mo symmetric="true">‖</mml:mo><mml:mi>R</mml:mi><mml:mo symmetric="true">‖</mml:mo></mml:mrow><mml:mo>⋅</mml:mo><mml:mrow><mml:mo symmetric="true">‖</mml:mo><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo symmetric="true">‖</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>+</mml:mo><mml:mrow><mml:mo symmetric="true">‖</mml:mo><mml:mrow><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo symmetric="true">‖</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:mrow><mml:mo symmetric="true">‖</mml:mo><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo symmetric="true">‖</mml:mo></mml:mrow><mml:mfrac><mml:mrow><mml:mi>H</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>⋅</mml:mo><mml:mi>P</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mrow><mml:mrow><mml:mo symmetric="true">‖</mml:mo><mml:mi>H</mml:mi><mml:mo symmetric="true">‖</mml:mo></mml:mrow><mml:mo>⋅</mml:mo><mml:mrow><mml:mo symmetric="true">‖</mml:mo><mml:mrow><mml:mi>p</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>x</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo symmetric="true">‖</mml:mo></mml:mrow></mml:mrow></mml:mfrac></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p>For each amino acid property, BPES<sub>i</sub> (w,m) calculates the value of the mutation (m) against the reference (w). For bpes(x), R is the eigen vector of a residue score, H is the eigen vector of a hydrophobic score, P is the eigen vector of the pH score, || || is a norm of the vector, x is the amino acid, and is the dot product.</p><p>APESS<disp-formula id="equ6"><mml:math id="m6"><mml:mrow><mml:mtable columnalign="left left" rowspacing="4pt" columnspacing="1em"><mml:mtr><mml:mtd><mml:mstyle displaystyle="true" scriptlevel="0"><mml:mi>A</mml:mi><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:mi>S</mml:mi><mml:mi>S</mml:mi><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mrow><mml:mi>n</mml:mi></mml:mrow></mml:munderover><mml:mrow><mml:mi>S</mml:mi><mml:mi>C</mml:mi><mml:mi>P</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>×</mml:mo><mml:mi>P</mml:mi><mml:mi>C</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>×</mml:mo><mml:mi>M</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo><mml:mo>×</mml:mo><mml:mi>B</mml:mi><mml:mi>P</mml:mi><mml:mi>E</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo stretchy="false">(</mml:mo><mml:mi>w</mml:mi><mml:mo>,</mml:mo><mml:mi>m</mml:mi><mml:mo stretchy="false">)</mml:mo></mml:mstyle></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math></disp-formula></p><p>APESS is the comprehensive value of SCPS, PCS, MR, and BPES. n is the number of positions, w means wild, and m means mutated.</p><p>The Kernel Density Estimator (kdeplot) from Python’s seaborn package was used to create a distribution function for APESS scores calculated across randomly sampled 30,000 SARS-CoV-2 sublineages sourced from GISAID. For all 7,335,614 sequences, we also calculated the scores and studied the distribution. This distribution function revealed that the SARS-CoV-2 lineages could be differentiated and characterized based on their APESS scores (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Based on this observation, we applied GMM to identify unique components of APESS score. We divided the range of the APESS score into two regions: the lower region for scores less than or equal to 3.2 and the upper region for scores greater than 3.2. To select the optimal number of components for GMM in each region, we used Bayesian Information Criterion (BIC), resulting in 4 and 5 as the optimal number of components in the lower and upper regions, respectively. We fit GMM for each region to construct prediction models with the corresponding optimal number of components.</p></sec><sec id="s4-10"><title>Analysis of gene regulation from SARS-CoV-2</title><p>We analyzed the differences in gene expression for various SARS-CoV-2 lineages when they infect the host. We downloaded GSE235262 from the Gene Expression Omnibus (GEO) to obtain data on human gene expression. Comparisons were made between controls (uninfected people), Alpha (B.1.1.7), Delta (B.1.617.2), Omicron (B.1.529), Omicron (BA.2), and Omicron (BA.4/BA.5 and its sublineages). Only the genes that showed significant expression levels (log2 (TPM +1)) were selected. We used enrichR (<ext-link ext-link-type="uri" xlink:href="https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.90">https://currentprotocols.onlinelibrary.wiley.com/doi/10.1002/cpz1.90</ext-link>) for the enrichment analysis of these selected genes then visualized the comparison between Delta and Omicron (BA.4/BA.5).</p></sec><sec id="s4-11"><title>SARS-CoV-2 variant prediction and machine learning model</title><p>The model predicted the probability of mutations in the RBM region of Alpha, Beta, Delta, and Omicron (BA.1, BA.2, BA.2.75, BA.4, BA.5, BQ.1, and XBB) variants and the 24 mutagenesis variants generated using machine learning. Eighteen variants were used for probability prediction. These were (N440K, V445P, G446S, N460K, S477N, T478K, E484A, F486P, F490S, Q498R, N501Y, Y505H, L452R, E484K, Q493R, G496S, F486V, and K444T). Additionally, a total of 24 VOCs (S477R, S477K, N439R, Y501R, N437R, S438R, S459R, S469R, S494R, T470R, T500R, Q493K, Q493R, T470K, T500K, S469K, S494K, Y501K, N437K, N439K, N460R, N460K, S438K, and S459K) excluding overlapping variants and variants lacking expression in data were also used for probability prediction (<xref ref-type="fig" rid="fig6s2">Figure 6—figure supplement 2</xref>).</p><p>The prediction was carried out using data collected from 2019-12-23 to 2023-05-17 (1242 d), and then with six different types of data, excluding specific clades:</p><list list-type="bullet"><list-item><p>The first group consists of clades before 21 M (Omicron B.1.1.529) including 19 A, 19B, 20 A, 20B, 20 C, 20D, 20E, 20 F, 20 G, 20 H, 20I, 20 J, 21 A, 21B, 21 C, 21D, 21E, 21 F, 21 G, 21 H, 21I, and 21 J.</p></list-item><list-item><p>The second group consisted of clades before 21 K (Omicron BA.1) and 21 L (Omicron ~BA.2), including the prior group and the addition of 21 M, 21 K, and 21 L.</p></list-item><list-item><p>The third group consisted of clades before 22D (Omicron BA.2.75) and 22 C (Omicron BA.2.12.1), including the prior group and the addition of 22 C and 22D.</p></list-item><list-item><p>The fourth group consists of clades before 22 A (Omicron BA.4) and 22B (Omicron, BA.5), including the prior group and the addition of 22 A and 22B.</p></list-item><list-item><p>The fifth group consisted of clades before 22E (Omicron BQ.1), including the prior group and the addition of 22E.</p></list-item><list-item><p>The sixth group consisted of clades before 22 F (Omicron XBB), 23 A (Omicron XBB 1.5), and 23 B (Omicron XBB), including the first group and the addition of 22 F, 23 A, and 23 B.</p></list-item></list><p>Machine learning determined the clade information and presence of mutations in 24 variants. The possibility of each variant is extracted through learning. Machine learning was performed using a LightGBM, which is a highly efficient gradient boosting decision tree, XGBoost, which is a scalable tree boosting system, Random Forest, which is a random forest guided tour, and an ensemble model that combined the three previous models. To calculate the probability of mutation occurrences, our custom script and the following libraries were used in Python 3.9.13. Data processing employed sci-kit-learn for scaling, data splitting, and accuracy assessment. In the case of machine learning, LightGBM and XGBoost utilized the ‘lightgbm’ and ‘xgboost’ libraries, respectively, to build their models. Meanwhile, the Random Forest and ensemble models utilized sci-kit-learn’s subfunctions to create their models. The deep learning model used TensorFlow and its lower-level library, Keras, for model development.</p></sec><sec id="s4-12"><title>The flow of data preprocessing and machine learning</title><p>We retrieved information from SARS-CoV-2 samples collected on GISAID from December 23, 2019, to May 17, 2023, spanning 1242 d. We filtered the data using various columns, including date, Nextstrain clade, species, substitution, AA substitution, deletion, and insertion, among others.</p><p>First, for species data, we extracted the data where the host was either ‘homo’ or ‘<italic>Homo sapiens.’</italic> Then, we removed the samples with date values that did not follow the ‘YYYY-MM-DD’ format. Based on the insertion, deletion, and AA substitution columns, we removed the samples where deletions, insertions, or nonsense mutations occurred. Following this, we removed columns other than date, clade, and lineage, and then eliminated samples with missing values (NaN).</p><p>For the extracted samples, we organized the amino acid mutation information from the AA substitution column for the 437–508 region of the S protein. We created columns indicating the presence (1) or absence (0) of 40 target mutations. We removed mutations not found in the GISAID data, leaving the columns representing the presence or absence of 24 mutations (N440K, V445P, G446S, N460K, S477N, T478K, E484A, F486P, F490S, Q498R, N501Y, Y505H, L452R, E484K, Q493R, G496S, F486V, K444T, S494R, T500R, Q493K, T470K, N439K, and N460R).</p><p>To prepare the filtered data for training, we transformed the values for the dates into integers, representing the number of days that had passed since the initial collection date. We then normalized these values to fall within the range of [0–1]. Using one-hot encoding, we preprocessed the Nextstrain clade information. From the preprocessed data, we created six datasets, each based on different clade groups. Finally, we used the random state function to generate the training and testing datasets used in the learning process.</p><p>The training data is used for learning as the input for five different models created. The learning model then predicts the likelihood of the occurrence of 24 target mutations (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>).</p></sec><sec id="s4-13"><title>Cell culture</title><p>HEK293T and 293T-hACE2 cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Welgene, South Korea) supplemented with 10% fetal bovine serum (FBS, Gibco) and 1% penicillin-streptomycin (Gibco) at 37℃ in a humidified 5% CO<sub>2</sub>. A HEK293T cell line stably expressing human ACE2, 293T-hACE2, was generated using a lentivirus-mediated gene transduction system under the antibiotic pressure of hygromycin. The identity of all cell lines was authenticated using short tandem repeat (STR) profiling. All cell lines were tested for mycoplasma contamination using PCR-based assays and confirmed to be mycoplasma-free.</p></sec><sec id="s4-14"><title>Molecular cloning and plasmid construction</title><p>The human codon-optimized full-length SARS-CoV-2 spike (Wuhan-Hu-1 strain) gene was obtained from Sino Biological Inc (Beijing, China). The last 19 amino acids of the SARS-CoV-2 spike were truncated to increase protein expression, and a flag tag was inserted at the C-terminal end. Spike gene mutation constructs, including D614G, N437R, N460K, D467P, D467I, and Q493R, were generated using a PlatinumTM SuperFi ll PCR Master Mix (Invitrogen, Waltham, MA, USA).</p></sec><sec id="s4-15"><title>Spike protein expression test</title><p>Viral spike genes were cloned into pcDNA3.1(+), and plasmid DNA was transfected into HEK293T cells using the PEI reagent (Sigma). After 48 hr, the cells were lysed with a 1% NP-40 lysis buffer (150 mM NaCl, 1% NP-40, 50 mM Tris-HCl), and the extracted proteins were analyzed by SDS-PAGE and immunoblotting. A mouse anti-FLAG antibody (Sigma) was used to detect spike protein expression.</p></sec><sec id="s4-16"><title>Pseudotyped virus and viral entry</title><p>The pseudotyped virus was generated from HEK293T cells (Invitrogen) by co-transfection with human immunodeficiency virus backbone plasmids expressing firefly luciferase as described previously. We used packaging plasmids (pLP1, pLP2, and pLP/VSV-G; all from Invitrogen) and pLVX-Luc-IRES-ZsGreen1_ Cat. 632187 (Luc stands for luciferase, and IRES stands for internal ribosomal entry site). For S protein pseudotyping, the full-length cDNA of the S gene (Sino Biological Inc) was cloned into pcDNA3 and used for transfection instead of pLP/VSV-G. A plasmid carrying the gene encoding the indicated mutation in the S protein was generated using a PlatinumTM SuperFi ll PCR Master Mix (Invitrogen, Waltham, MA, USA) based on the wild-type construct, and the point mutation was confirmed by sequencing. Viral supernatants were harvested 48 hr after transfection and normalized using the Lenti-X reverse transcription-quantitative PCR (qRT-PCR) titration kit _ Cat. 631235 according to the manufacturer’s protocol. Infected 293T-hACE2 cells were lysed 48 hr after infection and the efficiency of viral entry was measured by comparing the luciferase activity of pseudotyped viruses bearing the wild-type or mutant S protein. A VSV-G-pseudotyped lentivirus was used as a positive control. Relative luciferase activity in the cell lysates was measured using a luciferase assay kit (Promega).</p></sec><sec id="s4-17"><title>Cloning, expression, and purification of ACE2, SARS-CoV-2 RBD, and RBD variants</title><p>The SARS-CoV-2 spike protein RBD, and its mutations (N460K and Q493R), along with the N-terminal peptidase domain of human ACE2 was expressed using the Bac-to-Bac baculovirus system (Invitrogen). The RBD (Residues Arg319-Phe541) and the N-terminal peptidase domain of human ACE2 (Residues Ser19-Asp615) with an N-terminal gp67 signal peptide were cloned upstream of the cleavable deca-histidine tag and FLAG tag. RBD variants were introduced into the wild-type RBD construct using PCR-based site-directed mutagenesis. The resulting constructs were expressed in Spodoptera frugiperda (Sf9) insect cells and secreted into the medium after being cultured at 27 °C for 72 hr.</p><p>Subsequently, ACE2, RBD, and its variants were isolated from the filtered supernatant using a HisTrap Excel column (Cytiva, Marlborough, MA, USA). The C-terminal tags were cleaved using an in-house-generated HRV3C protease. The protease and cleaved C-terminal tags were removed using Ni-NTA resin (Takara, 635662), and the proteins were further purified by size-exclusion chromatography on a HiLoad 26/600 Superdex 200 pg (Cytiva). Purification was performed in a buffer containing 20 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 1 mM DTT. To maintain stability during storage, each protein sample was frozen at –80 °C and supplemented with 10% glycerol. For surface plasmon resonance (SPR), proteins were thawed from frozen storage immediately before the experiment.</p></sec><sec id="s4-18"><title>Binding affinity measurement</title><p>The SPR experiments were performed at room temperature using BiaCore T200 with a series of S CM5 sensor chips (Cytiva). The surfaces of the sample and reference flow cells were activated using a 1:1 mixture of NHS (N-hydroxysuccinimide) and EDC (3-(N,N-dimethylamino) propyl-N-ethylcarbodiimide). The reference flow cell was left blank. All the surfaces were blocked with ethanolamine (pH 8.0). HBS-EP + (Cytiva) was used as a running buffer.</p><p>For the binding affinity assay, the purified N-terminal domain of ACE2 was diluted in 10 mM sodium acetate buffer (pH 4.0) and immobilized on the chip at approximately 800 response units. The SARS-CoV-2 RBD and RBD mutations along the gradient were observed on the chip surface. After each cycle, the sensor surface was regenerated using 10 mM glycine-HCl (pH 2.5). The data were fitted to a 1:1 interaction steady-state binding model using BIAevaluation 3.1 software. Curve fitting was performed via nonlinear regression using a one-site-specific binding equation in GraphPad Prism version 8.4.0 (GraphPad Software, Boston, MA, USA).</p></sec><sec id="s4-19"><title>AIVE platform</title><p>The AIVE platform (<ext-link ext-link-type="uri" xlink:href="https://ai-ve.org/">https://ai-ve.org/</ext-link>) provides real-time protein structure predictions and APESS score calculations. AIVE reports the analysis results and mutation data from known sequences, randomly sampled SARS-CoV-2 sequences, or custom sequences provided by users. Based on the mutations in the SARS-CoV-2 lineages, Alphafold2 was utilized to analyze the protein structures. Using the Wuhan-Hu-1 sequence as a reference, we performed a comparative analysis of the main VOCs: Alpha, Beta, Delta, and Omicron. Reports are generated using visualization tools that provide Alphafold2 outputs such as pLDDT and PAE. Monomer folding and docking were visualized and scored. Differences caused by mutations are shown in the input amino acid sequences based on polarity and protein properties. APESS can predict the infectivity of sequences through the distribution of values obtained through the GMM prediction model and using previously known lineages. The results of the user’s APESS sequence scores can be visualized. AIVE runs on a high-performance computing (HPC) system with 3 RTX8700 GPUs, 96 CPUs, and 256 GB of main memory (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>).</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Software, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con5"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con6"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con7"><p>Data curation, Formal analysis</p></fn><fn fn-type="con" id="con8"><p>Data curation</p></fn><fn fn-type="con" id="con9"><p>Validation</p></fn><fn fn-type="con" id="con10"><p>Validation</p></fn><fn fn-type="con" id="con11"><p>Validation</p></fn><fn fn-type="con" id="con12"><p>Validation</p></fn><fn fn-type="con" id="con13"><p>Validation</p></fn><fn fn-type="con" id="con14"><p>Formal analysis, Validation</p></fn><fn fn-type="con" id="con15"><p>Validation</p></fn><fn fn-type="con" id="con16"><p>Validation</p></fn><fn fn-type="con" id="con17"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing – original draft, Project administration, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Supplementary tables.</title><p>(a) The number of polarity changes in the receptor binding motif (RBM). (b) The number of polarity changes in the spike protein. (c) Configuration of polarity changes caused by variants of concern (VOCs) in the RBM. (d) The number of amino acids in VOCs. (e) The number of transitions and transversions in the spike protein from viral sequences. (f) Epidemiological information (cases and deaths per million population) from Our World in Data (OWID). (g) Amino acid substitution of sublineages. (h) Symptomatic information (symptomatic and asymptomatic) from Global Initiative on Sharing All Influenza Data (GISAID). (i) Severity information (severe and mild) from GISAID. (j) Gene expression data between the Delta variant and Omicron (BA.4/5) variant from Gene Expression Omnibus (GEO) dataset. (k) Binding affinity between proteins in protein 3D structure using pDockQ. (i) Evaluation of hydrogen bonds (H-bond) through protein 3D structure prediction of SARS-CoV-2. (m) Binding affinity between proteins in protein 3D structure using HADDOCK. (n) The number of mutations per codon in the RBM. (o) The number of mutations per codon in the receptor binding domain (RBD). (p) The number of mutations per codon in the spike protein. (q) Amino acid property eigen selection score (APESS) score for each mutation with VOCs as the backbone. (r) Prediction of mutation probability using lightGBM. (s) Prediction of mutation probability using XGBoost. (t) Prediction of mutation probability using Random Forest. (u) Prediction of mutation probability using ensemble. (v) Prediction of mutation probability using deep learning. (w) The number of samples by clade in global SARS-CoV-2 analysis data. (x) Amino acid property values utilizing principal component analysis (PCA) clustering.</p></caption><media xlink:href="elife-99833-supp1-v2.xlsx" mimetype="application" mime-subtype="xlsx"/></supplementary-material><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-99833-mdarchecklist1-v2.docx" mimetype="application" mime-subtype="docx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>AIVE usage guide.</title></caption><media xlink:href="elife-99833-supp2-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All data supporting the findings reported here are available in the paper and Supplementary Information. The raw and processed data, custom scripts, and codes used in this study are deposited in the GitHub repository (<ext-link ext-link-type="uri" xlink:href="https://github.com/Honglab-Research/AIVE">https://github.com/Honglab-Research/AIVE</ext-link>, copy archived at <xref ref-type="bibr" rid="bib14">Honglab-Research, 2023</xref>), <ext-link ext-link-type="uri" xlink:href="https://github.com/Honglab-Research/AIVE-prediction">https://github.com/Honglab-Research/AIVE-prediction</ext-link> (copy archived at <xref ref-type="bibr" rid="bib15">Honglab-Research, 2024</xref>) and AIVE (<ext-link ext-link-type="uri" xlink:href="https://ai-ve.org">https://ai-ve.org</ext-link>).</p></sec><ack id="ack"><title>Acknowledgements</title><p>We thank the Global Science experimental Data hub Center (GSDC) and the Korea Research Environment Open NETwork (KREONET) service for data computing and networks provided by the Korea Institute of Science and Technology Information (KISTI).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali</surname><given-names>F</given-names></name><name><surname>Kasry</surname><given-names>A</given-names></name><name><surname>Amin</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant</article-title><source>Medicine in Drug Discovery</source><volume>10</volume><elocation-id>100086</elocation-id><pub-id pub-id-type="doi">10.1016/j.medidd.2021.100086</pub-id><pub-id pub-id-type="pmid">33681755</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ban</surname><given-names>X</given-names></name><name><surname>Lahiri</surname><given-names>P</given-names></name><name><surname>Dhoble</surname><given-names>AS</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Gu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>L</given-names></name><name><surname>Hong</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Kaustubh</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Evolutionary stability of salt bridges hints its contribution to stability of proteins</article-title><source>Computational and Structural Biotechnology Journal</source><volume>17</volume><fpage>895</fpage><lpage>903</lpage><pub-id pub-id-type="doi">10.1016/j.csbj.2019.06.022</pub-id><pub-id pub-id-type="pmid">31333816</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baral</surname><given-names>P</given-names></name><name><surname>Bhattarai</surname><given-names>N</given-names></name><name><surname>Hossen</surname><given-names>ML</given-names></name><name><surname>Stebliankin</surname><given-names>V</given-names></name><name><surname>Gerstman</surname><given-names>BS</given-names></name><name><surname>Narasimhan</surname><given-names>G</given-names></name><name><surname>Chapagain</surname><given-names>PP</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 Delta variant B.1.617.2 and implications for immune evasion</article-title><source>Biochemical and Biophysical Research Communications</source><volume>574</volume><fpage>14</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2021.08.036</pub-id><pub-id pub-id-type="pmid">34425281</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bergasa-Caceres</surname><given-names>F</given-names></name><name><surname>Rabitz</surname><given-names>HA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Interdiction of protein folding for therapeutic drug development in SARS CoV-2</article-title><source>The Journal of Physical Chemistry. B</source><volume>124</volume><fpage>8201</fpage><lpage>8208</lpage><pub-id pub-id-type="doi">10.1021/acs.jpcb.0c03716</pub-id><pub-id pub-id-type="pmid">32790379</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>DS</given-names></name><name><surname>Howser</surname><given-names>C</given-names></name><name><surname>Mehoke</surname><given-names>T</given-names></name><name><surname>Ernlund</surname><given-names>AW</given-names></name><name><surname>Evans</surname><given-names>JD</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>MutaGAN: A sequence-to-sequence GAN framework to predict mutations of evolving protein populations</article-title><source>Virus Evolution</source><volume>9</volume><elocation-id>vead022</elocation-id><pub-id pub-id-type="doi">10.1093/ve/vead022</pub-id><pub-id pub-id-type="pmid">37066021</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bhowmick</surname><given-names>S</given-names></name><name><surname>Jing</surname><given-names>T</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>EY</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>In silico protein folding prediction of covid-19 mutations and variants</article-title><source>Biomolecules</source><volume>12</volume><elocation-id>1665</elocation-id><pub-id pub-id-type="doi">10.3390/biom12111665</pub-id><pub-id pub-id-type="pmid">36359015</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bouhaddou</surname><given-names>M</given-names></name><name><surname>Reuschl</surname><given-names>A-K</given-names></name><name><surname>Polacco</surname><given-names>BJ</given-names></name><name><surname>Thorne</surname><given-names>LG</given-names></name><name><surname>Ummadi</surname><given-names>MR</given-names></name><name><surname>Ye</surname><given-names>C</given-names></name><name><surname>Rosales</surname><given-names>R</given-names></name><name><surname>Pelin</surname><given-names>A</given-names></name><name><surname>Batra</surname><given-names>J</given-names></name><name><surname>Jang</surname><given-names>GM</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Moen</surname><given-names>JM</given-names></name><name><surname>Richards</surname><given-names>AL</given-names></name><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Harjai</surname><given-names>B</given-names></name><name><surname>Stevenson</surname><given-names>E</given-names></name><name><surname>Rojc</surname><given-names>A</given-names></name><name><surname>Ragazzini</surname><given-names>R</given-names></name><name><surname>Whelan</surname><given-names>MVX</given-names></name><name><surname>Furnon</surname><given-names>W</given-names></name><name><surname>De Lorenzo</surname><given-names>G</given-names></name><name><surname>Cowton</surname><given-names>V</given-names></name><name><surname>Syed</surname><given-names>AM</given-names></name><name><surname>Ciling</surname><given-names>A</given-names></name><name><surname>Deutsch</surname><given-names>N</given-names></name><name><surname>Pirak</surname><given-names>D</given-names></name><name><surname>Dowgier</surname><given-names>G</given-names></name><name><surname>Mesner</surname><given-names>D</given-names></name><name><surname>Turner</surname><given-names>JL</given-names></name><name><surname>McGovern</surname><given-names>BL</given-names></name><name><surname>Rodriguez</surname><given-names>ML</given-names></name><name><surname>Leiva-Rebollo</surname><given-names>R</given-names></name><name><surname>Dunham</surname><given-names>AS</given-names></name><name><surname>Zhong</surname><given-names>X</given-names></name><name><surname>Eckhardt</surname><given-names>M</given-names></name><name><surname>Fossati</surname><given-names>A</given-names></name><name><surname>Liotta</surname><given-names>NF</given-names></name><name><surname>Kehrer</surname><given-names>T</given-names></name><name><surname>Cupic</surname><given-names>A</given-names></name><name><surname>Rutkowska</surname><given-names>M</given-names></name><name><surname>Mena</surname><given-names>I</given-names></name><name><surname>Aslam</surname><given-names>S</given-names></name><name><surname>Hoffert</surname><given-names>A</given-names></name><name><surname>Foussard</surname><given-names>H</given-names></name><name><surname>Olwal</surname><given-names>CO</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Zwaka</surname><given-names>T</given-names></name><name><surname>Pham</surname><given-names>J</given-names></name><name><surname>Lyons</surname><given-names>M</given-names></name><name><surname>Donohue</surname><given-names>L</given-names></name><name><surname>Griffin</surname><given-names>A</given-names></name><name><surname>Nugent</surname><given-names>R</given-names></name><name><surname>Holden</surname><given-names>K</given-names></name><name><surname>Deans</surname><given-names>R</given-names></name><name><surname>Aviles</surname><given-names>P</given-names></name><name><surname>Lopez-Martin</surname><given-names>JA</given-names></name><name><surname>Jimeno</surname><given-names>JM</given-names></name><name><surname>Obernier</surname><given-names>K</given-names></name><name><surname>Fabius</surname><given-names>JM</given-names></name><name><surname>Soucheray</surname><given-names>M</given-names></name><name><surname>Hüttenhain</surname><given-names>R</given-names></name><name><surname>Jungreis</surname><given-names>I</given-names></name><name><surname>Kellis</surname><given-names>M</given-names></name><name><surname>Echeverria</surname><given-names>I</given-names></name><name><surname>Verba</surname><given-names>K</given-names></name><name><surname>Bonfanti</surname><given-names>P</given-names></name><name><surname>Beltrao</surname><given-names>P</given-names></name><name><surname>Sharan</surname><given-names>R</given-names></name><name><surname>Doudna</surname><given-names>JA</given-names></name><name><surname>Martinez-Sobrido</surname><given-names>L</given-names></name><name><surname>Patel</surname><given-names>AH</given-names></name><name><surname>Palmarini</surname><given-names>M</given-names></name><name><surname>Miorin</surname><given-names>L</given-names></name><name><surname>White</surname><given-names>K</given-names></name><name><surname>Swaney</surname><given-names>DL</given-names></name><name><surname>Garcia-Sastre</surname><given-names>A</given-names></name><name><surname>Jolly</surname><given-names>C</given-names></name><name><surname>Zuliani-Alvarez</surname><given-names>L</given-names></name><name><surname>Towers</surname><given-names>GJ</given-names></name><name><surname>Krogan</surname><given-names>NJ</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>SARS-CoV-2 variants evolve convergent strategies to remodel the host response</article-title><source>Cell</source><volume>186</volume><fpage>4597</fpage><lpage>4614</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2023.08.026</pub-id><pub-id pub-id-type="pmid">37738970</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bryant</surname><given-names>P</given-names></name><name><surname>Pozzati</surname><given-names>G</given-names></name><name><surname>Elofsson</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Improved prediction of protein-protein interactions using AlphaFold2</article-title><source>Nature Communications</source><volume>13</volume><elocation-id>1265</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-022-28865-w</pub-id><pub-id pub-id-type="pmid">35273146</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Hou</surname><given-names>D</given-names></name><name><surname>Tai</surname><given-names>W</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Im</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>XF</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction</article-title><source>Biophysical Journal</source><volume>120</volume><fpage>1011</fpage><lpage>1019</lpage><pub-id pub-id-type="doi">10.1016/j.bpj.2021.02.007</pub-id><pub-id pub-id-type="pmid">33607086</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Jian</surname><given-names>F</given-names></name><name><surname>Xiao</surname><given-names>T</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Yisimayi</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>An</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Niu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>S</given-names></name><name><surname>Liang</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>Cui</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Du</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Hao</surname><given-names>X</given-names></name><name><surname>Shao</surname><given-names>F</given-names></name><name><surname>Jin</surname><given-names>R</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xie</surname><given-names>XS</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies</article-title><source>Nature</source><volume>602</volume><fpage>657</fpage><lpage>663</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-04385-3</pub-id><pub-id pub-id-type="pmid">35016194</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Azman</surname><given-names>AS</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Tian</surname><given-names>Y</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Ge</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Leung</surname><given-names>DT</given-names></name><name><surname>Domman</surname><given-names>DB</given-names></name><name><surname>Yu</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Global landscape of SARS-CoV-2 genomic surveillance and data sharing</article-title><source>Nature Genetics</source><volume>54</volume><fpage>499</fpage><lpage>507</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01033-y</pub-id><pub-id pub-id-type="pmid">35347305</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadfield</surname><given-names>J</given-names></name><name><surname>Megill</surname><given-names>C</given-names></name><name><surname>Bell</surname><given-names>SM</given-names></name><name><surname>Huddleston</surname><given-names>J</given-names></name><name><surname>Potter</surname><given-names>B</given-names></name><name><surname>Callender</surname><given-names>C</given-names></name><name><surname>Sagulenko</surname><given-names>P</given-names></name><name><surname>Bedford</surname><given-names>T</given-names></name><name><surname>Neher</surname><given-names>RA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Nextstrain: real-time tracking of pathogen evolution</article-title><source>Bioinformatics</source><volume>34</volume><fpage>4121</fpage><lpage>4123</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bty407</pub-id><pub-id pub-id-type="pmid">29790939</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Han</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Peng</surname><given-names>Q</given-names></name><name><surname>Su</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Tian</surname><given-names>M</given-names></name><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>K</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Gao</surname><given-names>GF</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Receptor binding and complex structures of human ACE2 to spike RBD from omicron and delta SARS-CoV-2</article-title><source>Cell</source><volume>185</volume><fpage>630</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.01.001</pub-id><pub-id pub-id-type="pmid">35093192</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Honglab-Research</collab></person-group><year iso-8601-date="2023">2023</year><data-title>AIVE</data-title><version designator="swh:1:rev:095b018c31384e0e20bf1c643bed7dd5fbd40414">swh:1:rev:095b018c31384e0e20bf1c643bed7dd5fbd40414</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:a319c5add134b653f2ef21419067d71292d86b3f;origin=https://github.com/Honglab-Research/AIVE;visit=swh:1:snp:591f6175be9f2f00c66184fa1878725609ecfcd3;anchor=swh:1:rev:095b018c31384e0e20bf1c643bed7dd5fbd40414">https://archive.softwareheritage.org/swh:1:dir:a319c5add134b653f2ef21419067d71292d86b3f;origin=https://github.com/Honglab-Research/AIVE;visit=swh:1:snp:591f6175be9f2f00c66184fa1878725609ecfcd3;anchor=swh:1:rev:095b018c31384e0e20bf1c643bed7dd5fbd40414</ext-link></element-citation></ref><ref id="bib15"><element-citation publication-type="software"><person-group person-group-type="author"><collab>Honglab-Research</collab></person-group><year iso-8601-date="2024">2024</year><data-title>AIVE-prediction</data-title><version designator="swh:1:rev:9401d4b10b4e73656721583c0fa000bcbcb3aa6e">swh:1:rev:9401d4b10b4e73656721583c0fa000bcbcb3aa6e</version><source>Software Heritage</source><ext-link ext-link-type="uri" xlink:href="https://archive.softwareheritage.org/swh:1:dir:7dcacb61c2ba57e13ce44670682421e064348e94;origin=https://github.com/Honglab-Research/AIVE-prediction;visit=swh:1:snp:43ee045b188b050cc9af87db2f4dca13ecf17543;anchor=swh:1:rev:9401d4b10b4e73656721583c0fa000bcbcb3aa6e">https://archive.softwareheritage.org/swh:1:dir:7dcacb61c2ba57e13ce44670682421e064348e94;origin=https://github.com/Honglab-Research/AIVE-prediction;visit=swh:1:snp:43ee045b188b050cc9af87db2f4dca13ecf17543;anchor=swh:1:rev:9401d4b10b4e73656721583c0fa000bcbcb3aa6e</ext-link></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>T</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Cheng</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The key amino acids of E protein involved in early flavivirus infection: viral entry</article-title><source>Virology Journal</source><volume>18</volume><elocation-id>136</elocation-id><pub-id pub-id-type="doi">10.1186/s12985-021-01611-2</pub-id><pub-id pub-id-type="pmid">34217298</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>MM</given-names></name><name><surname>Kobayashi</surname><given-names>K</given-names></name><name><surname>Kidokoro</surname><given-names>SI</given-names></name><name><surname>Kuroda</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Hydrophobic surface residues can stabilize a protein through improved water-protein interactions</article-title><source>The FEBS Journal</source><volume>286</volume><fpage>4122</fpage><lpage>4134</lpage><pub-id pub-id-type="doi">10.1111/febs.14941</pub-id><pub-id pub-id-type="pmid">31175706</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ito</surname><given-names>J</given-names></name><name><surname>Suzuki</surname><given-names>R</given-names></name><name><surname>Uriu</surname><given-names>K</given-names></name><name><surname>Itakura</surname><given-names>Y</given-names></name><name><surname>Zahradnik</surname><given-names>J</given-names></name><name><surname>Kimura</surname><given-names>KT</given-names></name><name><surname>Deguchi</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Lytras</surname><given-names>S</given-names></name><name><surname>Tamura</surname><given-names>T</given-names></name><name><surname>Kida</surname><given-names>I</given-names></name><name><surname>Nasser</surname><given-names>H</given-names></name><name><surname>Shofa</surname><given-names>M</given-names></name><name><surname>Begum</surname><given-names>MM</given-names></name><name><surname>Tsuda</surname><given-names>M</given-names></name><name><surname>Oda</surname><given-names>Y</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>J</given-names></name><name><surname>Sasaki-Tabata</surname><given-names>K</given-names></name><name><surname>Fujita</surname><given-names>S</given-names></name><name><surname>Yoshimatsu</surname><given-names>K</given-names></name><name><surname>Ito</surname><given-names>H</given-names></name><name><surname>Nao</surname><given-names>N</given-names></name><name><surname>Asakura</surname><given-names>H</given-names></name><name><surname>Nagashima</surname><given-names>M</given-names></name><name><surname>Sadamasu</surname><given-names>K</given-names></name><name><surname>Yoshimura</surname><given-names>K</given-names></name><name><surname>Yamamoto</surname><given-names>Y</given-names></name><name><surname>Nagamoto</surname><given-names>T</given-names></name><name><surname>Kuramochi</surname><given-names>J</given-names></name><name><surname>Schreiber</surname><given-names>G</given-names></name><collab>Genotype to Phenotype Japan (G2P-Japan) Consortium</collab><name><surname>Saito</surname><given-names>A</given-names></name><name><surname>Matsuno</surname><given-names>K</given-names></name><name><surname>Takayama</surname><given-names>K</given-names></name><name><surname>Hashiguchi</surname><given-names>T</given-names></name><name><surname>Tanaka</surname><given-names>S</given-names></name><name><surname>Fukuhara</surname><given-names>T</given-names></name><name><surname>Ikeda</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant</article-title><source>Nature Communications</source><volume>14</volume><elocation-id>2671</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-023-38188-z</pub-id><pub-id pub-id-type="pmid">37169744</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>BA</given-names></name><name><surname>Xie</surname><given-names>X</given-names></name><name><surname>Bailey</surname><given-names>AL</given-names></name><name><surname>Kalveram</surname><given-names>B</given-names></name><name><surname>Lokugamage</surname><given-names>KG</given-names></name><name><surname>Muruato</surname><given-names>A</given-names></name><name><surname>Zou</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Juelich</surname><given-names>T</given-names></name><name><surname>Smith</surname><given-names>JK</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Bopp</surname><given-names>N</given-names></name><name><surname>Schindewolf</surname><given-names>C</given-names></name><name><surname>Vu</surname><given-names>M</given-names></name><name><surname>Vanderheiden</surname><given-names>A</given-names></name><name><surname>Winkler</surname><given-names>ES</given-names></name><name><surname>Swetnam</surname><given-names>D</given-names></name><name><surname>Plante</surname><given-names>JA</given-names></name><name><surname>Aguilar</surname><given-names>P</given-names></name><name><surname>Plante</surname><given-names>KS</given-names></name><name><surname>Popov</surname><given-names>V</given-names></name><name><surname>Lee</surname><given-names>B</given-names></name><name><surname>Weaver</surname><given-names>SC</given-names></name><name><surname>Suthar</surname><given-names>MS</given-names></name><name><surname>Routh</surname><given-names>AL</given-names></name><name><surname>Ren</surname><given-names>P</given-names></name><name><surname>Ku</surname><given-names>Z</given-names></name><name><surname>An</surname><given-names>Z</given-names></name><name><surname>Debbink</surname><given-names>K</given-names></name><name><surname>Diamond</surname><given-names>MS</given-names></name><name><surname>Shi</surname><given-names>P-Y</given-names></name><name><surname>Freiberg</surname><given-names>AN</given-names></name><name><surname>Menachery</surname><given-names>VD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis</article-title><source>Nature</source><volume>591</volume><fpage>293</fpage><lpage>299</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03237-4</pub-id><pub-id pub-id-type="pmid">33494095</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><name><surname>Tunyasuvunakool</surname><given-names>K</given-names></name><name><surname>Bates</surname><given-names>R</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Potapenko</surname><given-names>A</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Meyer</surname><given-names>C</given-names></name><name><surname>Kohl</surname><given-names>SAA</given-names></name><name><surname>Ballard</surname><given-names>AJ</given-names></name><name><surname>Cowie</surname><given-names>A</given-names></name><name><surname>Romera-Paredes</surname><given-names>B</given-names></name><name><surname>Nikolov</surname><given-names>S</given-names></name><name><surname>Jain</surname><given-names>R</given-names></name><name><surname>Adler</surname><given-names>J</given-names></name><name><surname>Back</surname><given-names>T</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Reiman</surname><given-names>D</given-names></name><name><surname>Clancy</surname><given-names>E</given-names></name><name><surname>Zielinski</surname><given-names>M</given-names></name><name><surname>Steinegger</surname><given-names>M</given-names></name><name><surname>Pacholska</surname><given-names>M</given-names></name><name><surname>Berghammer</surname><given-names>T</given-names></name><name><surname>Bodenstein</surname><given-names>S</given-names></name><name><surname>Silver</surname><given-names>D</given-names></name><name><surname>Vinyals</surname><given-names>O</given-names></name><name><surname>Senior</surname><given-names>AW</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>JM</given-names></name><name><surname>Ranganathan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>pDOCK: a new technique for rapid and accurate docking of peptide ligands to Major Histocompatibility Complexes</article-title><source>Immunome Research</source><volume>6 Suppl 1</volume><elocation-id>S2</elocation-id><pub-id pub-id-type="doi">10.1186/1745-7580-6-S1-S2</pub-id><pub-id pub-id-type="pmid">20875153</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilim</surname><given-names>O</given-names></name><name><surname>Mentes</surname><given-names>A</given-names></name><name><surname>Pál</surname><given-names>B</given-names></name><name><surname>Csabai</surname><given-names>I</given-names></name><name><surname>Gellért</surname><given-names>Á</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>SARS-CoV-2 receptor-binding domain deep mutational AlphaFold2 structures</article-title><source>Scientific Data</source><volume>10</volume><elocation-id>134</elocation-id><pub-id pub-id-type="doi">10.1038/s41597-023-02035-z</pub-id><pub-id pub-id-type="pmid">36918581</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleine-Weber</surname><given-names>H</given-names></name><name><surname>Elzayat</surname><given-names>MT</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Graham</surname><given-names>BS</given-names></name><name><surname>Müller</surname><given-names>MA</given-names></name><name><surname>Drosten</surname><given-names>C</given-names></name><name><surname>Pöhlmann</surname><given-names>S</given-names></name><name><surname>Hoffmann</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Mutations in the spike protein of middle east respiratory syndrome coronavirus transmitted in korea increase resistance to antibody-mediated neutralization</article-title><source>Journal of Virology</source><volume>93</volume><elocation-id>e01381-18</elocation-id><pub-id pub-id-type="doi">10.1128/JVI.01381-18</pub-id><pub-id pub-id-type="pmid">30404801</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lins</surname><given-names>L</given-names></name><name><surname>Brasseur</surname><given-names>R</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>The hydrophobic effect in protein folding</article-title><source>FASEB Journal</source><volume>9</volume><fpage>535</fpage><lpage>540</lpage><pub-id pub-id-type="doi">10.1096/fasebj.9.7.7737462</pub-id><pub-id pub-id-type="pmid">7737462</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mathieu</surname><given-names>E</given-names></name><name><surname>Ritchie</surname><given-names>H</given-names></name><name><surname>Ortiz-Ospina</surname><given-names>E</given-names></name><name><surname>Roser</surname><given-names>M</given-names></name><name><surname>Hasell</surname><given-names>J</given-names></name><name><surname>Appel</surname><given-names>C</given-names></name><name><surname>Giattino</surname><given-names>C</given-names></name><name><surname>Rodés-Guirao</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>A global database of COVID-19 vaccinations</article-title><source>Nature Human Behaviour</source><volume>5</volume><fpage>947</fpage><lpage>953</lpage><pub-id pub-id-type="doi">10.1038/s41562-021-01122-8</pub-id><pub-id pub-id-type="pmid">33972767</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pace</surname><given-names>CN</given-names></name><name><surname>Fu</surname><given-names>H</given-names></name><name><surname>Fryar</surname><given-names>KL</given-names></name><name><surname>Landua</surname><given-names>J</given-names></name><name><surname>Trevino</surname><given-names>SR</given-names></name><name><surname>Shirley</surname><given-names>BA</given-names></name><name><surname>Hendricks</surname><given-names>MM</given-names></name><name><surname>Iimura</surname><given-names>S</given-names></name><name><surname>Gajiwala</surname><given-names>K</given-names></name><name><surname>Scholtz</surname><given-names>JM</given-names></name><name><surname>Grimsley</surname><given-names>GR</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Contribution of hydrophobic interactions to protein stability</article-title><source>Journal of Molecular Biology</source><volume>408</volume><fpage>514</fpage><lpage>528</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2011.02.053</pub-id><pub-id pub-id-type="pmid">21377472</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panchin</surname><given-names>AY</given-names></name><name><surname>Panchin</surname><given-names>YV</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Excessive G-U transversions in novel allele variants in SARS-CoV-2 genomes</article-title><source>PeerJ</source><volume>8</volume><elocation-id>e9648</elocation-id><pub-id pub-id-type="doi">10.7717/peerj.9648</pub-id><pub-id pub-id-type="pmid">33194341</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peacock</surname><given-names>TP</given-names></name><name><surname>Goldhill</surname><given-names>DH</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Baillon</surname><given-names>L</given-names></name><name><surname>Frise</surname><given-names>R</given-names></name><name><surname>Swann</surname><given-names>OC</given-names></name><name><surname>Kugathasan</surname><given-names>R</given-names></name><name><surname>Penn</surname><given-names>R</given-names></name><name><surname>Brown</surname><given-names>JC</given-names></name><name><surname>Sanchez-David</surname><given-names>RY</given-names></name><name><surname>Braga</surname><given-names>L</given-names></name><name><surname>Williamson</surname><given-names>MK</given-names></name><name><surname>Hassard</surname><given-names>JA</given-names></name><name><surname>Staller</surname><given-names>E</given-names></name><name><surname>Hanley</surname><given-names>B</given-names></name><name><surname>Osborn</surname><given-names>M</given-names></name><name><surname>Giacca</surname><given-names>M</given-names></name><name><surname>Davidson</surname><given-names>AD</given-names></name><name><surname>Matthews</surname><given-names>DA</given-names></name><name><surname>Barclay</surname><given-names>WS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets</article-title><source>Nature Microbiology</source><volume>6</volume><fpage>899</fpage><lpage>909</lpage><pub-id pub-id-type="doi">10.1038/s41564-021-00908-w</pub-id><pub-id pub-id-type="pmid">33907312</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pettersen</surname><given-names>EF</given-names></name><name><surname>Goddard</surname><given-names>TD</given-names></name><name><surname>Huang</surname><given-names>CC</given-names></name><name><surname>Meng</surname><given-names>EC</given-names></name><name><surname>Couch</surname><given-names>GS</given-names></name><name><surname>Croll</surname><given-names>TI</given-names></name><name><surname>Morris</surname><given-names>JH</given-names></name><name><surname>Ferrin</surname><given-names>TE</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>UCSF ChimeraX: Structure visualization for researchers, educators, and developers</article-title><source>Protein Science</source><volume>30</volume><fpage>70</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1002/pro.3943</pub-id><pub-id pub-id-type="pmid">32881101</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruch</surname><given-names>TR</given-names></name><name><surname>Machamer</surname><given-names>CE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>The hydrophobic domain of infectious bronchitis virus E protein alters the host secretory pathway and is important for release of infectious virus</article-title><source>Journal of Virology</source><volume>85</volume><fpage>675</fpage><lpage>685</lpage><pub-id pub-id-type="doi">10.1128/JVI.01570-10</pub-id><pub-id pub-id-type="pmid">21047962</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senior</surname><given-names>AW</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Kirkpatrick</surname><given-names>J</given-names></name><name><surname>Sifre</surname><given-names>L</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Qin</surname><given-names>C</given-names></name><name><surname>Žídek</surname><given-names>A</given-names></name><name><surname>Nelson</surname><given-names>AWR</given-names></name><name><surname>Bridgland</surname><given-names>A</given-names></name><name><surname>Penedones</surname><given-names>H</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Simonyan</surname><given-names>K</given-names></name><name><surname>Crossan</surname><given-names>S</given-names></name><name><surname>Kohli</surname><given-names>P</given-names></name><name><surname>Jones</surname><given-names>DT</given-names></name><name><surname>Silver</surname><given-names>D</given-names></name><name><surname>Kavukcuoglu</surname><given-names>K</given-names></name><name><surname>Hassabis</surname><given-names>D</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Improved protein structure prediction using potentials from deep learning</article-title><source>Nature</source><volume>577</volume><fpage>706</fpage><lpage>710</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1923-7</pub-id><pub-id pub-id-type="pmid">31942072</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seyran</surname><given-names>M</given-names></name><name><surname>Takayama</surname><given-names>K</given-names></name><name><surname>Uversky</surname><given-names>VN</given-names></name><name><surname>Lundstrom</surname><given-names>K</given-names></name><name><surname>Palù</surname><given-names>G</given-names></name><name><surname>Sherchan</surname><given-names>SP</given-names></name><name><surname>Attrish</surname><given-names>D</given-names></name><name><surname>Rezaei</surname><given-names>N</given-names></name><name><surname>Aljabali</surname><given-names>AAA</given-names></name><name><surname>Ghosh</surname><given-names>S</given-names></name><name><surname>Pizzol</surname><given-names>D</given-names></name><name><surname>Chauhan</surname><given-names>G</given-names></name><name><surname>Adadi</surname><given-names>P</given-names></name><name><surname>Mohamed Abd El-Aziz</surname><given-names>T</given-names></name><name><surname>Soares</surname><given-names>AG</given-names></name><name><surname>Kandimalla</surname><given-names>R</given-names></name><name><surname>Tambuwala</surname><given-names>M</given-names></name><name><surname>Hassan</surname><given-names>SS</given-names></name><name><surname>Azad</surname><given-names>GK</given-names></name><name><surname>Pal Choudhury</surname><given-names>P</given-names></name><name><surname>Baetas-da-Cruz</surname><given-names>W</given-names></name><name><surname>Serrano-Aroca</surname><given-names>Á</given-names></name><name><surname>Brufsky</surname><given-names>AM</given-names></name><name><surname>Uhal</surname><given-names>BD</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The structural basis of accelerated host cell entry by SARS-CoV-2†</article-title><source>The FEBS Journal</source><volume>288</volume><fpage>5010</fpage><lpage>5020</lpage><pub-id pub-id-type="doi">10.1111/febs.15651</pub-id><pub-id pub-id-type="pmid">33264497</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shekhawat</surname><given-names>U</given-names></name><name><surname>Roy Chowdhury Chakravarty</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Computational and comparative investigation of hydrophobic profile of spike protein of SARS-CoV-2 and SARS-CoV</article-title><source>Journal of Biological Physics</source><volume>48</volume><fpage>399</fpage><lpage>414</lpage><pub-id pub-id-type="doi">10.1007/s10867-022-09615-x</pub-id><pub-id pub-id-type="pmid">36422744</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>Y</given-names></name><name><surname>McCauley</surname><given-names>J</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>GISAID: Global initiative on sharing all influenza data - from vision to reality</article-title><source>Euro Surveillance</source><volume>22</volume><elocation-id>30494</elocation-id><pub-id pub-id-type="doi">10.2807/1560-7917.ES.2017.22.13.30494</pub-id><pub-id pub-id-type="pmid">28382917</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Theodosiou</surname><given-names>AA</given-names></name><name><surname>Read</surname><given-names>RC</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Artificial intelligence, machine learning and deep learning: Potential resources for the infection clinician</article-title><source>The Journal of Infection</source><volume>87</volume><fpage>287</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2023.07.006</pub-id><pub-id pub-id-type="pmid">37468046</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thirunavukarasu</surname><given-names>AJ</given-names></name><name><surname>Ting</surname><given-names>DSJ</given-names></name><name><surname>Elangovan</surname><given-names>K</given-names></name><name><surname>Gutierrez</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>TF</given-names></name><name><surname>Ting</surname><given-names>DSW</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>Large language models in medicine</article-title><source>Nature Medicine</source><volume>29</volume><fpage>1930</fpage><lpage>1940</lpage><pub-id pub-id-type="doi">10.1038/s41591-023-02448-8</pub-id><pub-id pub-id-type="pmid">37460753</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsai</surname><given-names>KC</given-names></name><name><surname>Lee</surname><given-names>YC</given-names></name><name><surname>Tseng</surname><given-names>TS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Comprehensive deep mutational scanning reveals the immune-escaping hotspots of sars-cov-2 receptor-binding domain targeting neutralizing antibodies</article-title><source>Frontiers in Microbiology</source><volume>12</volume><elocation-id>698365</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2021.698365</pub-id><pub-id pub-id-type="pmid">34335530</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Zundert</surname><given-names>GCP</given-names></name><name><surname>Rodrigues</surname><given-names>J</given-names></name><name><surname>Trellet</surname><given-names>M</given-names></name><name><surname>Schmitz</surname><given-names>C</given-names></name><name><surname>Kastritis</surname><given-names>PL</given-names></name><name><surname>Karaca</surname><given-names>E</given-names></name><name><surname>Melquiond</surname><given-names>ASJ</given-names></name><name><surname>van Dijk</surname><given-names>M</given-names></name><name><surname>de Vries</surname><given-names>SJ</given-names></name><name><surname>Bonvin</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The haddock2.2 web server: user-friendly integrative modeling of biomolecular complexes</article-title><source>Journal of Molecular Biology</source><volume>428</volume><fpage>720</fpage><lpage>725</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2015.09.014</pub-id><pub-id pub-id-type="pmid">26410586</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>L-YR</given-names></name><name><surname>Zheng</surname><given-names>J</given-names></name><name><surname>Sariol</surname><given-names>A</given-names></name><name><surname>Lowery</surname><given-names>S</given-names></name><name><surname>Meyerholz</surname><given-names>DK</given-names></name><name><surname>Gallagher</surname><given-names>T</given-names></name><name><surname>Perlman</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Middle East respiratory syndrome coronavirus Spike protein variants exhibit geographic differences in virulence</article-title><source>PNAS</source><volume>118</volume><elocation-id>e2102983118</elocation-id><pub-id pub-id-type="doi">10.1073/pnas.2102983118</pub-id><pub-id pub-id-type="pmid">34099556</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Nasrallah</surname><given-names>IM</given-names></name><name><surname>Shou</surname><given-names>H</given-names></name><name><surname>Wen</surname><given-names>J</given-names></name><name><surname>Doshi</surname><given-names>J</given-names></name><name><surname>Habes</surname><given-names>M</given-names></name><name><surname>Erus</surname><given-names>G</given-names></name><name><surname>Abdulkadir</surname><given-names>A</given-names></name><name><surname>Resnick</surname><given-names>SM</given-names></name><name><surname>Albert</surname><given-names>MS</given-names></name><name><surname>Maruff</surname><given-names>P</given-names></name><name><surname>Fripp</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>JC</given-names></name><name><surname>Wolk</surname><given-names>DA</given-names></name><name><surname>Davatzikos</surname><given-names>C</given-names></name><collab>iSTAGING Consortium</collab><collab>Baltimore Longitudinal Study of Aging (BLSA)</collab><collab>Alzheimer’s Disease Neuroimaging Initiative (ADNI)</collab></person-group><year iso-8601-date="2021">2021</year><article-title>A deep learning framework identifies dimensional representations of Alzheimer’s Disease from brain structure</article-title><source>Nature Communications</source><volume>12</volume><elocation-id>7065</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-021-26703-z</pub-id><pub-id pub-id-type="pmid">34862382</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>A</given-names></name><name><surname>PourNejatian</surname><given-names>N</given-names></name><name><surname>Shin</surname><given-names>HC</given-names></name><name><surname>Smith</surname><given-names>KE</given-names></name><name><surname>Parisien</surname><given-names>C</given-names></name><name><surname>Compas</surname><given-names>C</given-names></name><name><surname>Martin</surname><given-names>C</given-names></name><name><surname>Costa</surname><given-names>AB</given-names></name><name><surname>Flores</surname><given-names>MG</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Magoc</surname><given-names>T</given-names></name><name><surname>Harle</surname><given-names>CA</given-names></name><name><surname>Lipori</surname><given-names>G</given-names></name><name><surname>Mitchell</surname><given-names>DA</given-names></name><name><surname>Hogan</surname><given-names>WR</given-names></name><name><surname>Shenkman</surname><given-names>EA</given-names></name><name><surname>Bian</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>A large language model for electronic health records</article-title><source>NPJ Digital Medicine</source><volume>5</volume><elocation-id>194</elocation-id><pub-id pub-id-type="doi">10.1038/s41746-022-00742-2</pub-id><pub-id pub-id-type="pmid">36572766</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname><given-names>K</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Bleazard</surname><given-names>T</given-names></name><name><surname>Kim</surname><given-names>T</given-names></name><name><surname>Youk</surname><given-names>J</given-names></name><name><surname>Ju</surname><given-names>YS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Mutational spectrum of SARS-CoV-2 during the global pandemic</article-title><source>Experimental &amp; Molecular Medicine</source><volume>53</volume><fpage>1229</fpage><lpage>1237</lpage><pub-id pub-id-type="doi">10.1038/s12276-021-00658-z</pub-id><pub-id pub-id-type="pmid">34453107</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Chai</surname><given-names>Y</given-names></name><name><surname>Zheng</surname><given-names>Z</given-names></name><name><surname>Kot</surname><given-names>AC</given-names></name><name><surname>Zhou</surname><given-names>Z</given-names></name></person-group><year iso-8601-date="2023">2023</year><article-title>TEMPO: A transformer-based mutation prediction framework for SARS-CoV-2 evolution</article-title><source>Computers in Biology and Medicine</source><volume>152</volume><elocation-id>106264</elocation-id><pub-id pub-id-type="doi">10.1016/j.compbiomed.2022.106264</pub-id><pub-id pub-id-type="pmid">36535209</pub-id></element-citation></ref></ref-list></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99833.3.sa0</article-id><title-group><article-title>eLife Assessment</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ng</surname><given-names>Alvin WT</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution>Lee Kong Chian School of Medicine</institution><country>Singapore</country></aff></contrib></contrib-group><kwd-group kwd-group-type="evidence-strength"><kwd>Solid</kwd></kwd-group><kwd-group kwd-group-type="claim-importance"><kwd>Valuable</kwd></kwd-group></front-stub><body><p>The study provides <bold>valuable</bold> insight into the biological significance of SARS-CoV-2 by using a series of computational analyses of viral proteins. While the evidence is <bold>solid</bold>, the reviewers noted a lack of clarity about the objectives of the analyses. While impactful for the field, the manuscript would benefit from improved presentation.</p></body></sub-article><sub-article article-type="referee-report" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99833.3.sa1</article-id><title-group><article-title>Reviewer #1 (Public Review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>Park et al. conducted various analyses attempting to elucidate the biological significance of SARS-CoV-2 mutations. However, the study lacks a clear objective. The specific goals of the analyses in each subsection are unclear, as is how the results from these subsections are interconnected. Compiling results from unrelated analyses into a single paper can be confusing for readers. Clarifying the objective and narrowing down the topics would make the paper's purpose clearer.</p><p>The logic of the study is also unclear. For instance, the authors developed an evaluation score, APESS, for analyzing viral sequences. Although they state that the APESS score correlates with viral infectivity, there is no explanation in the results section about why this is the case.</p><p>In summary, I recommend reconsidering the structure of the paper.</p></body></sub-article><sub-article article-type="referee-report" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99833.3.sa2</article-id><title-group><article-title>Reviewer #2 (Public review):</article-title></title-group><contrib-group><contrib contrib-type="author"><anonymous/><role specific-use="referee">Reviewer</role></contrib></contrib-group></front-stub><body><p>Summary:</p><p>The authors have developed a machine learning tool AIVE to predict the infectivity of SARS-CoV-2 variants and also a scoring metric to measure infectivity. A large number of virus sequences were used with very detailed analysis that incorporates hydrophoic, hydrophiclic, acid and alkaline characteristics. The protein structures were also considered to measure infectivity and search for core mutations. The study especially focused on the S protein of SARS-CoV-2. The contents of this study would be of interest to many researchers related to this area and the web-service would be helpful to easily analyze such data without indepth bioinformatics expertise.</p><p>Strengths:</p><p>- Analysis on large scale data</p><p>- Experimental validation on a partial set of searched mutations</p><p>- A user-friendly web-based analysis platform that is made public</p><p>Weaknesses:</p><p>- Complexity of the research</p><p>Comments on revisions:</p><p>The authors have addressed all my comments and is much more readable.</p></body></sub-article><sub-article article-type="author-comment" id="sa3"><front-stub><article-id pub-id-type="doi">10.7554/eLife.99833.3.sa3</article-id><title-group><article-title>Author response</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Park</surname><given-names>Jongkeun</given-names></name><role specific-use="author">Author</role><aff><institution>Catholic University of Korea</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>WonJong</given-names></name><role specific-use="author">Author</role><aff><institution>Catholic University of Korea</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Seong</surname><given-names>Do Young</given-names></name><role specific-use="author">Author</role><aff><institution>Catholic University of Korea</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Jeong</surname><given-names>Seungpil</given-names></name><role specific-use="author">Author</role><aff><institution>Catholic University of Korea</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Ju Young</given-names></name><role specific-use="author">Author</role><aff><institution>Catholic University of Korea</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Park</surname><given-names>Hyo Jeong</given-names></name><role specific-use="author">Author</role><aff><institution>Catholic University of Korea</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Chung</surname><given-names>Dae Sun</given-names></name><role specific-use="author">Author</role><aff><institution>Catholic University of Korea</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Yi</surname><given-names>Kijong</given-names></name><role specific-use="author">Author</role><aff><institution>Korea Advanced Institute of Science and Technology</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Uijin</given-names></name><role specific-use="author">Author</role><aff><institution>Yonsei University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Yoon</surname><given-names>Ga-Yeon</given-names></name><role specific-use="author">Author</role><aff><institution>Yonsei University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Hyeran</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Taehoon</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Ko</surname><given-names>Sooyeon</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Min</surname><given-names>Eun Jeong</given-names></name><role specific-use="author">Author</role><aff><institution>Catholic University of Korea</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Hyun-Soo</given-names></name><role specific-use="author">Author</role><aff><institution>Yonsei University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Cho</surname><given-names>Nam-Hyuk</given-names></name><role specific-use="author">Author</role><aff><institution>Seoul National University</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib><contrib contrib-type="author"><name><surname>Hong</surname><given-names>Dongwan</given-names></name><role specific-use="author">Author</role><aff><institution>Catholic University of Korea</institution><addr-line><named-content content-type="city">Seoul</named-content></addr-line><country>Republic of Korea</country></aff></contrib></contrib-group></front-stub><body><p>The following is the authors’ response to the original reviews.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Public review):</bold></p><p>Summary:</p><p>Park et al. conducted various analyses attempting to elucidate the biological significance of SARS-CoV-2 mutations. However, the study lacks a clear objective. The specific goals of the analyses in each subsection are unclear, as is how the results from these subsections are interconnected. Compiling results from unrelated analyses into a single paper can be confusing for readers. Clarifying the objective and narrowing down the topics would make the paper's purpose clearer.</p><p>The logic of the study is also unclear. For instance, the authors developed an evaluation score, APESS, for analyzing viral sequences. Although they state that the APESS score correlates with viral infectivity, there is no explanation in the results section about why this is the case.</p><p>The structure of the paper should be reconsidered.</p></disp-quote><p>Thank you for your feedback. We have heeded the input that the study lacks a clear objective and made sure that the overall goal of the study is reflected in the Abstract, Results, and Discussion.</p><p>We have made sure that the specific goals in each subsection are clearer in the Results section that better explain the goals of those sections and elaborated on how the components of our study connect to each other. We have addressed these in more detail in the ‘Recommendations for the authors’ section.</p><p>Thank you for the feedback on APESS, our evaluation model. APESS was created based on virus properties that we discovered of SARS-CoV-2 in our study. When applying our evaluation model, high APESS scores indicated high infectivity. APESS is calculated from a comprehensive evaluation of SARS-CoV-2 at the nucleotide, amino acid, and protein structure levels.</p><p>The detailed explanations and exact calculations of APESS are detailed in the Materials and Methods section in line 571 but we should have been more detailed in the Results section as well. We have made sure to properly indicate this in the Results section in line 284.</p><p>And overall, we have made edits to the manuscript that accurately explain our research by amending terms, restructuring arguments, and providing more clarity for the interconnectivity of the research.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Public review):</bold></p><p>Summary:</p><p>The authors have developed a machine learning tool AIVE to predict the infectivity of SARS-CoV-2 variants and also a scoring metric to measure infectivity. A large number of virus sequences were used with a very detailed analysis that incorporates hydrophobic, hydrophilic, acid, and alkaline characteristics. The protein structures were also considered to measure infectivity and search for core mutations. The study especially focused on the S protein of SARS-CoV-2. The contents of this study would be of interest to many researchers related to this area and the web service would be helpful to easily analyze such data without in-depth bioinformatics expertise.</p><p>Strengths:</p><p>- Analysis of large-scale data.</p><p>- Experimental validation on a partial set of searched mutations.</p><p>- A user-friendly web-based analysis platform that is made public.</p><p>Weaknesses:</p><p>- Complexity of the research.</p></disp-quote><p>Thank you for your kind feedback. Our study explored a wide range of topics including biochemical properties, machine learning, and viral infectivity.</p><p>In presenting our research, we recognize that our comprehensive analysis may have slightly obscured the specific aims and overall objective of the study. We investigated properties in the viral sequences of SARS-CoV-2 and examined big data, clinical data, and expression data to elucidate their effect on viral infectivity. We then used evaluation modeling and in silico and in vitro validation.</p><p>We have clarified the aims of our research and improved upon the flow of the manuscript by adding sentences that outline the goals of our research in the appropriate sub sections of the Results and Discussion sections.</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #1 (Recommendations for the authors):</bold></p><p>The abstract should clearly state the backgrounds, objectives, strategies, and findings of this study in an orderly manner.</p></disp-quote><p>Thank you for your feedback. We have restructured the Abstract to better reflect the goals and methods of our study. We start the Abstract by introducing the background of the study ‘An unprecedented amount of SARS-CoV-2 data has been accumulated compared with previous infectious diseases, enabling insights into its evolutionary process and more thorough analyses.’ in line 48. Then we more clearly stated the overall objectives of our research in line 50 as ‘This study investigates SARS-CoV-2 features as it evolves to evaluate its infectivity.’ Then, we clearly defined our specific discoveries in the virus, the purpose of our evaluation model, and how we validated our findings.</p><disp-quote content-type="editor-comment"><p>In the Introduction, the message of each paragraph is unclear. Please clearly state the objectives of the study and what was done to achieve these objectives.</p></disp-quote><p>Thank you for the feedback. We have updated the Introduction section to more clearly state the objectives of the study.</p><p>To increase clarity, we have moved ‘Furthermore, hydrophobic properties in the amino acid sequence affect protein folding. Coronavirus hydrophobicity has significant effects on amino acid properties and protein folding.’ to line 127.</p><p>In line 130, we rephrased the first sentence of the paragraph to ‘For these prior approaches to virus analysis and prediction, expertise with the relevant fields is required for a full understanding.’ to better establish the link between the background information and aims of the study. Then in line 134, we added ‘elucidate properties about the virus’ to clarify the aims of the study.</p><p>In line 141, we have improved the clarity of the sentence to better present the scope and objectives of the study.</p><disp-quote content-type="editor-comment"><p>The relationship between the sections in the Results is unclear. Clarify why each section is necessary and how they are interconnected.</p></disp-quote><p>We investigated properties in the viral sequences of SARS-CoV-2 that highlighted amino acid substitutions or changes in polarity (Figure 1). In VOCs, we noted trends or absences of amino acid substitutions at specific positions (Figure 2). We examined epidemiological and clinical data to determine the infectivity, severity, and symptomaticity of lineages. Looking at expression data and binding affinity further illuminated the effect of amino acid substitutions (Figure 3). We created APESS, an evaluation modeling, that is comprehensively calculated from the nucleotide, amino acid, and protein structure levels of the virus. Evaluation of lineages revealed that higher APESS scores were associated with higher infectivity (Figure 4). We used in silico and in vitro validation to reinforce our findings then used machine learning to make predictions on future developments (Figure 5). We created candidate sequences for evaluation and utilized machine learning in predictions (Figure 6).</p><p>We have added explanations to each section in Results that elucidate the objective of each section and how they connect with each other in the wider study.</p><p>In line 157, we have added ‘We examined the amino acid sequences of SARS-CoV-2 to make discoveries about biochemical properties.’ to clearly outline the objective of the subsection.</p><p>In line 207, we have improved the phrasing of the sentence.</p><p>In line 278, we stressed that ‘We developed APESS, an evaluation model to analyze viral sequences based on the nucleotide, amino acid, and protein structure properties.’ to properly define the purpose and background of APESS.</p><disp-quote content-type="editor-comment"><p>Please define abbreviations when they first appear.</p></disp-quote><p>We have added the full terms for the stated abbreviations in the relevant sections of the manuscript.</p><p>In line 107, we have added the proper abbreviation for Our World in Data (OWID).</p><p>In lines 143, 175, and 489 we have added the full term for Variants of Concern (VOCs).</p><p>In line 160, we have added the full term for Receptor Binding Motif (RBM).</p><disp-quote content-type="editor-comment"><p><bold>Reviewer #2 (Recommendations for the authors):</bold></p><p>(1) pg 9, line 51, full name of RBM should be declared.</p></disp-quote><p>We have added the full name of Receptor Binding Motif (RBM) to the appropriate section in the Abstract.</p><disp-quote content-type="editor-comment"><p>(2) How are the Variants of Concern (VOCs) defined?</p></disp-quote><p>Thank you for the comment and we apologize for the confusion. Variants of Concern as defined by the World Health Organization are specified in the Materials and Methods section. We have also added the full name for Variants of Concern (VOCs) when they are first mentioned in the Introduction and Results sections.</p><disp-quote content-type="editor-comment"><p>(3) pg 17, line 297. The purpose of using AI/ML to predict amino acid substitutions at specific locations is not clear. The VOCs and related mutation loci were already searched, so the AA substitution prediction step seems a little repetitive. Is it to create customized sequences? Also, if prediction (or probability) was made, some performance evaluation would be helpful.</p></disp-quote><p>Thank you for this feedback. The purpose of utilizing machine learning to make predictions about amino acid substitutions is to assess the possibility of amino acid substitutions occurring at specific locations. These potential amino acid substitutions were evaluated by APESS to have high scores, linking them to high infectivity. As the feedback suggests, amino acid substitutions in VOCs are researched but our prediction sought to ascertain the likelihood of amino acid substitutions that our evaluation model associated with infectivity. In the Results section in line 330, we assessed the probability of amino acid substitutions N460K and Q493R that the study found to be significant. The datasets that we utilized for these predictions are detailed in the Materials and Methods section in line 677.</p><p>The models we trained with machine learning predicted the probability of mutations based on samples in each group and their performance was evaluated by comparing the presence of mutations in the clades they diverged from. We have added the following sentences to line 330: “We used Accuracy, Precision, Recall, and F1 score to evaluate performance. All models showed high performance scores above 0.95 in Precision, Recall, and F1 score. For accuracy, XGBoost, scored above 0.89, exhibiting relatively high performance while LightGBM scored above 0.78.”</p><disp-quote content-type="editor-comment"><p>(4) pg 17, line 289. The objective of creating candidate lineages is not clear and would be helpful for the readers if its purpose is elaborated on. Since there are enough SARS-CoV-2 sequences, wouldn't it be more realistic and accurate to use those real sequences instead of creating them? Furthermore, the candidate lineages should be defined but they were missing in this section. This part made it a little difficult to follow the overall paper's logic.</p></disp-quote><p>The manuscript should have been clearer on what ‘candidate lineages’ signified, we apologize for the confusion. In line 314, we included the following sentences for clarity: ‘We introduced amino acid substitutions at specific locations in the SARS-CoV-2 backbone for the wildtype and VOCs. The amino acid substitutions were lysine (K), arginine (R), asparagine (N), serine (S), tyrosine (Y), and glycine (G). We then evaluated the infectivity of these candidate lineages with our evaluation model APESS.’</p><p>The purpose of creating candidate lineages in our study was to assess the effect of specific amino acid substitutions on the virus’ infectivity. The amino acid substitutions we evaluated were lysine (K), arginine (R), asparagine (N), serine (S), tyrosine (Y), and glycine (G). We determined that examining the introduction of specific amino acid substitutions to SARS-CoV-2 sequences would highlight the significance they had on infectivity. We have revised the paragraph in line 314 of the Results section to convey what we were doing.</p><disp-quote content-type="editor-comment"><p>(5) This study covers very detailed contents regarding lineages, mutations, and their effect on infectivity. It would be more readable if subsections could be added per group of investigation, especially in the results and discussion section.</p></disp-quote><p>In the Results section, we have emphasized the objective of each subsection and how they connect with one another for the overall goals of our study.</p><p>In line 157, we have added ‘We examined the amino acid sequences of SARS-CoV-2 to make discoveries about biochemical properties.’ to clearly outline the objective of the subsection.</p><p>In line 207, we have improved the phrasing of the sentence.</p><p>In line 278, we stressed that ‘We developed APESS, an evaluation model to analyze viral sequences based on the nucleotide, amino acid, and protein structure properties.’ to properly define the purpose and background of APESS.</p><p>We have made edits to the Discussion section to more clearly indicate subsections.</p><p>In line 389, we have added ‘In our investigation of various viruses’ to clearly indicate the background on other viruses.</p><p>In line 409, we added the sentence ‘We made discoveries on specific amino acid substitutions at positions.’ to indicate the subsection talking about N437R, N460K, and D467 mutations.</p><p>In line 471, we added the sentence ‘We created AIVE to feature our findings and analyses on an online platform.’ And modified the following sentence to better explain AIVE.</p><disp-quote content-type="editor-comment"><p>(6) pg 26, line 557. The criteria for the SCPSi scores were set to 0.9 and 0.1 by the proportion of the Omicron and Delta variants. How do other criteria affect the performance of the method?</p></disp-quote><p>Thank you for the question and check point. We used 0.9/0.1 for our initial criteria in our SCPS calculation. To determine how that affected performance, we have used 0.8/0.2 and 0.7/0.3 as the criteria.</p><p>After calculating APESS with different SCPS weights (0.9/0.1, 0.8/0/2, 0.7/0.3), we used a Gaussian Mixture Model (GMM) to compare how the groups were divided based on APESS. All three groups with different SCPS weights were determined to accurately reflect data patterns when they had four components.</p><p>When comparing parameter values, the group that used the original weights of 0.9 and 0.1 for SCPS showed the lowest values for variance and standard error across all four components. This indicates that each component was stable and clearly distinguishable from one another.</p><p>The group where the weights were adjusted to 0.7 and 0.3 for SCPS showed significantly higher variance and a large error for the G2 component. The distribution of each component was more widespread, signifying that the stability and reliability was lower.</p><p>The group where the weights were adjusted to 0.8 and 0.2 for SCPS was positioned between the two previous groups for finer data classification and reliability. However, the group notably lacked reliability when it came to the SE values for the G4 component.</p><p>Thus, the original model with 0.9 and 0.1 weight is the most reliable.</p><p>When the Gaussian Density for each group was plotted, the group with 0.9/0.1 SCPS weights showed the highest peak near 2 (G1), with a value of approximately 2. For the group with SCPS 0.8/0.2 weights, the highest peak appeared near 4.2 (G3), showing a high value around 14. For the group with SCPS 0.7/0.3 weights, the highest peak appeared near 3.7 (G3) showing a value around 5. The group with 0.9/0.1 SCPS weights exhibited a more uniform Gaussian distribution compared to the other two.</p><fig id="sa3fig1" position="float"><label>Author response image 1.</label><caption><title>Superposition of Gaussian Densities for SCPS weight 0.9/0.1.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-sa3-fig1-v2.tif"/></fig><table-wrap id="sa3table1" position="float"><label>Author response table 1.</label><caption><title>Statistical values of the Superposition of Gaussian Densities for SCPS weight 0.9/0.1.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle">Component</th><th align="left" valign="top">mean</th><th align="left" valign="top">variance</th><th align="left" valign="middle">se</th><th align="left" valign="middle">weight</th></tr></thead><tbody><tr><td align="left" valign="middle">G1</td><td align="left" valign="middle">2.0642</td><td align="left" valign="middle">0.0034</td><td align="left" valign="middle">0.058309519</td><td align="left" valign="middle">0.4104</td></tr><tr><td align="left" valign="middle">G2</td><td align="left" valign="middle">1.8725</td><td align="left" valign="middle">0.0778</td><td align="left" valign="middle">0.278926514</td><td align="left" valign="middle">0.0388</td></tr><tr><td align="left" valign="middle">G3</td><td align="left" valign="middle">0.0263</td><td align="left" valign="middle">0.0056</td><td align="left" valign="middle">0.074833148</td><td align="left" valign="middle">0.2024</td></tr><tr><td align="left" valign="middle">G4</td><td align="left" valign="middle">1.6404</td><td align="left" valign="middle">0</td><td align="left" valign="middle">0</td><td align="left" valign="middle">0.3484</td></tr></tbody></table></table-wrap><fig id="sa3fig2" position="float"><label>Author response image 2.</label><caption><title>Superposition of Gaussian Densities for SCPS weight 0.8/0.2.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-sa3-fig2-v2.tif"/></fig><table-wrap id="sa3table2" position="float"><label>Author response table 2.</label><caption><title>Statistical values of the Superposition of Gaussian Densities for SCPS weight 0.8/0.2.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle">Component</th><th align="left" valign="middle">mean</th><th align="left" valign="top">variance</th><th align="left" valign="top">se</th><th align="left" valign="middle">weight</th></tr></thead><tbody><tr><td align="left" valign="middle">G1</td><td align="char" char="." valign="middle">0</td><td align="char" char="hyphen" valign="middle">1.00E-06</td><td align="char" char="." valign="middle">0.001</td><td align="char" char="." valign="middle">0.191166653</td></tr><tr><td align="left" valign="middle">G2</td><td align="char" char="." valign="middle">8.434051839</td><td align="char" char="." valign="middle">0.004907285</td><td align="char" char="." valign="middle">0.070052018</td><td align="char" char="." valign="middle">0.226271799</td></tr><tr><td align="left" valign="middle">G3</td><td align="char" char="." valign="middle">4.210249767</td><td align="char" char="hyphen" valign="middle">1.00E-06</td><td align="char" char="." valign="middle">0.001</td><td align="char" char="." valign="middle">0.353961013</td></tr><tr><td align="left" valign="middle">G4</td><td align="char" char="." valign="middle">6.758534282</td><td align="char" char="." valign="middle">2.463725537</td><td align="char" char="." valign="middle">1.569625923</td><td align="char" char="." valign="middle">0.228600536</td></tr></tbody></table></table-wrap><fig id="sa3fig3" position="float"><label>Author response image 3.</label><caption><title>Superposition of Gaussian Densities for SCPS weight 0.7/0.3.</title></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-99833-sa3-fig3-v2.tif"/></fig><table-wrap id="sa3table3" position="float"><label>Author response table 3.</label><caption><title>Statistical values of the Superposition of Gaussian Densities for SCPS weight 0.7/0.3.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle">Component</th><th align="left" valign="top">mean</th><th align="left" valign="top">variance</th><th align="left" valign="top">se</th><th align="left" valign="top">weight</th></tr></thead><tbody><tr><td align="left" valign="middle">G1</td><td align="char" char="." valign="middle">0</td><td align="char" char="hyphen" valign="middle">1.00E-06</td><td align="char" char="." valign="middle">0.001</td><td align="char" char="." valign="middle">0.19116666</td></tr><tr><td align="left" valign="middle">G2</td><td align="char" char="." valign="middle">7.306207524</td><td align="char" char="." valign="middle">2.700755873</td><td align="char" char="." valign="middle">1.643397661</td><td align="char" char="." valign="middle">0.229009764</td></tr><tr><td align="left" valign="middle">G3</td><td align="char" char="." valign="middle">3.683968546</td><td align="char" char="hyphen" valign="middle">1.00E-06</td><td align="char" char="." valign="middle">0.001</td><td align="char" char="." valign="middle">0.353987719</td></tr><tr><td align="left" valign="middle">G4</td><td align="char" char="." valign="middle">9.478264495</td><td align="char" char="." valign="middle">0.011051658</td><td align="char" char="." valign="middle">0.105126865</td><td align="char" char="." valign="middle">0.225835857</td></tr></tbody></table></table-wrap><disp-quote content-type="editor-comment"><p>(7) Overall, the approach is very detailed and realistic. Just curious if this approach would be also applicable to other viruses such as influenza.</p></disp-quote><p>We appreciate the insightful comments from the reviewer, and this is a direction we hope to take our research in the future. Our study focused on SARS-CoV-2 and the properties we discovered from the virus’ spike protein interacting with the host’s ACE2 receptor. In our investigation of other coronaviruses such as MERS-CoV, SARS-CoV-1 possesses a different structure and properties than these viruses as we have illustrated in Supplementary Figure 24. We had provided explanations about our investigation of other viruses in the Discussion section. In line 389, we have added ‘In our investigation of various viruses’ to better signpost this section.</p></body></sub-article></article>